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Abstract 
Type 2 diabetes affects 90% of people who live with this chronic disease.  A primary goal of 
healthcare professionals is to assist patients with Type 2 diabetes to achieve optimal glycemic 
control to prevent the devastating complications of this disease.  Research has demonstrated that 
optimal glycemic control can minimize or prevent macrovascular complications such as heart 
attack or stroke and the microvascular complications of retinopathy, nephropathy, and 
neuropathy.  Historically insulin has been one of the last agents to be added in type 2 diabetes 
despite its efficacy and long term treatment data.  Reluctance by both patients and clinicians to 
add insulin to treatment regimens, a phenomenon known as psychological insulin resistance, 
remains an issue.  The perception of stress and ways of coping in participants who were initiating 
insulin therapy were examined in this research.  The relationship between participants’ stress and 
the education they received was also examined.  The education provided was based upon a 
Registered Nurses Association of Ontario (RNAO) Best Practice Guideline (BPG). 
In a pretest / posttest design, participants (N = 105) who were seen at a Diabetes Education 
Centre for initiation of insulin therapy were surveyed prior to receiving insulin initiation 
education and six weeks following the initiation of their insulin therapy.  Three surveys were 
completed, the Perceived Stress Scale, Ways of Coping Questionnaire, and The Confidence in 
Administering Insulin and Managing Diet Scale at the pre/post timepoints.  A BPG evaluation 
tool was also completed during the posttest appointment.  A mediated regression analysis 
demonstrated coping to be a mediator of the relationship between stress and insulin self-efficacy.  
There was a statistically significant decrease in participants’ stress and a statistically significant 
increase in insulin self-efficacy.  Analysis of the BPG evaluation tool demonstrated that 80% of 
the BPG content was recalled by participants.  This study provided evidence that the needs of 
these patients can be met with structured education through the use of a Best Practice Guideline 
and the assessment of patient stress and coping can improve patient self-efficacy with insulin 
therapy and decrease their stress burden. 
 
Keywords 
Type 2 diabetes, insulin initiation, stress, coping, best practice guidelines, Registered Nurses 
Association of Ontario, psychological insulin resistance, education 
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Chapter 1 
1. Introduction 
This chapter provides the foundation for the development of the research presented in this 
dissertation.  It begins with the research questions that were examined, articulates the elements of 
this integrated thesis, and concludes with an executive summary of the dissertation. 
1.1 Background  
Evidence regarding the earliest awareness of diabetes dates back to 1552 BC with the description 
by an Egyptian physician of the “passing of too much urine” (Canadian Diabetes Association, 
2013c).  Today as diabetes continues to increase throughout the world, particularly Type 2 
diabetes,  a person dies every 6 seconds from this chronic disease (International Diabetes 
Federation, 2013).  In Canada, approximately 2.6 million Canadians are living with diabetes 
(Public Health Agency of Canada, 2011).  Although diabetes care continues to evolve and the 
number of pharmacologic agents used to treat diabetes has expanded greatly, the reality is that 
approximately half of Canadians living with type 2 diabetes do not achieve the recommended 
clinical practice guideline targets for glycemic control (Harris, Kapor, Lank, Willan, & Houston, 
2010a; Leiter et al., 2013a).   
Achieving optimal blood glucose control is critical in diabetes to minimize the devastating 
complications of this disease.  Persons living with diabetes have mortality rates at least two times 
higher than those without diabetes (Public Health Agency of Canada, 2011a).  The risk of 
macrovascular complications such as heart attack, stroke or microvascular complications such as 
renal failure, retinopathy, and neuropathy are all increased in the presence of diabetes.  The 
importance of glycemic control was demonstrated in the landmark research of the United 
Kingdom Prospective Diabetes Study (UKPDS) which examined and established the standards 
for blood glucose control in Type 2 diabetes (1998).  Study findings revealed a 12% lower risk of 
developing any diabetes-related endpoints with substantial risk-reduction in microvascular 
complications for patients in the intensive glucose group compared to patients in the control 
group.  The findings became the foundation for developing the standard of care for diabetes 
clinical management. 
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The reasons for not achieving target blood glucose control are complex, multifactorial, and must 
take into consideration both the pathophysiologic and psychological elements of living with 
diabetes.  As a nurse practitioner, my clinical practice has included many patients who have 
struggled with their diabetes self-management.  The need to add insulin to a therapeutic regimen 
has often resulted in anxiety for patients and has frequently been met with resistance or refusal.  
This study was an important way for me to fulfill my professional commitment as a researcher 
and educator to add to the diabetes research findings.  The results provide new knowledge 
regarding the education and initiation of insulin therapy in adult patients with Type 2 diabetes. 
1.2 Significance 
As members of the interprofessional diabetes team, nurses play a key role in the education of 
people living with diabetes.  The majority of diabetes care originates in the primary care setting 
with the focus on enhancing diabetes self-management skills (Clement, Harvey, Rabi, Roscoe, & 
Sherifali, 2013).   The role of the nurse in out-patient diabetes care has a strong focus on 
education and assisting patients to develop effective self- management behaviours.  In a meta-
analysis of the effectiveness of  structured care to improve the management of patients with 
diabetes, Renders (2001) found that enhancing the role of the nurse led to improvements in 
patient outcomes and process of care.  Nurses are frequently involved with medication 
management and have been shown to assist with improving glycemic control  (Barr-Taylor et al., 
2003; Hearnshaw et al., 2006; The California Medi-Cal Type 2 Diabetes Study., 2004; Wens et 
al., 2008).  With the recognition that nursing care must be evidenced-based, the use of best 
practice guidelines (BPG) provides the synthesis of research and clinical expertise required to 
support the highest caliber of nursing care.  Utilizing and evaluating BPGs are integral to 
effective and efficient nursing care.   
1.3 Research Purpose and Questions 
The purpose of this research was to examine the relationships between perceived stress and ways 
of coping of patients with Type 2 diabetes who began insulin therapy and received diabetes 
education guided by the Registered Nurses Association of Ontario (RNAO) Best Practice 
Guideline (BPG) for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
(2009).  The research questions were: 
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1. What is the relationship between perceived stress and diabetes education guided by the 
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
who initiate insulin therapy? 
2. What is the relationship between perceived stress, ways of coping in adult patients and the       
initiation of insulin therapy in adults with Type 2 diabetes? 
3. What is the level of participant recall of diabetes education using the RNAO BPG for the 
Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes as evaluated by a 
novel BPG evaluation tool? 
4. What is the patient experience of initiating insulin therapy when receiving structured Best 
Practice Guideline diabetes education?” 
 
The research findings for question #1 and question #2 are discussed in chapter 3, “Coping as a 
Mediator of Stress with the Initiation of Insulin in Type 2 Diabetes”.  Chapter 4, “Evaluating the 
Use of a Best Practice Guideline with Insulin Initiation in Type 2 Diabetes” presents findings for 
questions #3 and #4. 
1.4 Research Approach  
The theory to frame this study was Lazarus and Folkman’s (1984) cognitive theory of stress and 
coping.  The theory provides a framework for examining psychological stress and holds that 
stress is contextual, an interaction between the person and his/her environment.  Folkman (1997) 
further revised the model to include positive psychological states.  As defined by Lazarus and 
Folkman, stress is “a relationship between the person and the environment that is appraised by 
the person as taxing or exceeding his or her resources and endangering his or her well-being”  
(Lazarus & Folkman, 1984, p. 21).  Stress is not considered to be static and is purported to 
change over time as a result of interaction between the individual and their environment.    
The definition of coping depends on the theoretical framework or context in which coping is 
identified.  Coping is described as a dynamic system which is highly interactive (Folkman, 
2010).   Coping varies amongst individuals based on the “intensity of their emotion response and 
their ability to regulate it, the opportunities inherent in the situation for problem solving, and 
changes in the person-environment relationship as the situation unfolds” (Folkman & Greer, 
2000, p. 13).  This statement regarding coping is consistent with Bandura’s conceptualization of 
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coping, his view being that a person’s beliefs in their coping capabilities can affect the level of 
stress experienced in threatening or difficult situations (1994). 
The hypothesized relationships between the study variables: RNAO BPG education, stress, 
coping, and self-efficacy with initiation of insulin therapy are illustrated in Figure 1.   
 
 
1.5 Method 
A pretest / posttest, non-experimental design was undertaken using one group of participants.  
Participants were insulin and injection therapy naïve.  Convenience sampling was used to obtain 
a final sample size of 105, calculated to provide a medium effect size of 0.15, an alpha error 
probability of 0.05 and a power calculation of 0.80 assuming a 10% withdrawal or failure to 
complete study rate.  Participants’ stress scores were measured with the following validated 
tools:  Perceived Stress Scale (Cohen, Kamarck, & Mermelstein, 1983).  Coping (ways of 
coping) was measured with the WAYS questionnaire (Folkman & Lazarus, 1988).  The 
Confidence in Administering Insulin-Managing Diet Scale questionnaire developed specifically 
for use with the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 
2 Diabetes was utilized to measure participants’  insulin therapy self-efficacy (B. Davies et al., 
2006).   A BPG evaluation tool developed by the author for this study measured participants’ 
recall of the BPG contents. Participants were  surveyed just prior to beginning insulin therapy 
and then approximately six weeks following initiation of insulin therapy at scheduled 
appointments at a Diabetes Education Centre (DEC). 
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Descriptive and inferential analyses were performed using the IBM SPSS Statistics v. 22 (IBM., 
2013).  Paired-samples t-tests and a mediated regression analysis were undertaken to answer the 
research questions.  Content analysis was utilized to examine qualitative data obtained from the 
BGP evaluation tool.  
1.6 Integrated Thesis Article Format 
This dissertation is structured in the integrated article format as regulated by the School of 
Graduate and Postdoctoral Studies at Western University, London, Ontario.  Chapter 1 provides 
an introduction of the foundations for the dissertation research.  Chapters 2, 3, and 4 are 
independent, original articles submitted for publication in peer-reviewed journals relevant to the 
content of each article.  Chapter 5 provides an integrated summary of the dissertation work. 
Chapter 2, ‘Stress and Coping in Patients with Type 2 Diabetes Initiating Insulin:  A Scoping Review’  
This is the first of three articles for publication.  This scoping review was undertaken to map the 
literature, sources of evidence, and gaps in the published research related to stress and coping 
when patients initiate insulin therapy.  Literature between 2001 and 2013 was reviewed.  Policy 
mapping was included within the scoping review to identify documents and statements from 
professional bodies that influence the nature of practice within the speciality of diabetes.  
Additionally policy mapping was done to identify educational strategies currently in place and 
offer direction for future educational strategies.  The selection process of identifying relevant 
studies resulted in nine items that most closely aligned with the research questions and nine 
documents that related to the policy mapping.   
Two themes emerged from the scoping review (a) insulin initiation barriers and (b) coping.  The 
findings reinforced the importance of the psychological aspect of diabetes care which can be 
critical for successful self-management of diabetes especially for patients requiring insulin 
therapy.  The policy mapping identified comprehensive evidence-based clinical practice 
guidelines and policy frameworks available as resources for diabetes care.  More importantly, 
there was increasing evidence of integration and recognition of the psychological elements of 
diabetes care into these resources. 
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Chapter 3, ‘Coping as a Mediator of Stress with the Initiation of Insulin in Type 2 Diabetes’ 
The second article presents the results of the data analysis of the study variables perceived stress, 
ways of coping, and insulin initiation self-efficacy.  A final sample was obtained from three 
independent Diabetes Education Centres (N = 105).  For research question #1, What is the 
relationship between perceived stress and education guided by the RNAO BPG for Subcutaneous 
Administration of Insulin in Adult Patients with Type 2 Diabetes?, there was a statistically 
significant (p < 0.05) decrease in the pretest to posttest scores for perceived stress and increase in 
scores for insulin self-efficacy.  Results showed that patient stress decreased and insulin self-
efficacy increased after receiving the RNAO BPG insulin initiation education. 
Question #2, What is the relationship between perceived stress, ways of coping and the initiation 
of insulin therapy in adults with type 2 diabetes?  This question was analyzed using mediated 
regression and correlations.  The correlational analysis revealed a moderately positive correlation 
between stress and coping and a weak, inverse correlation between stress and insulin initiation 
self-efficacy.  The relationship between coping and insulin initiation self-efficacy was non-
significant. 
The mediated regression analysis examined the relationship between perceived stress and insulin 
initiation self-efficacy with coping as a mediator.  A bias-corrected bootstrap estimate of the 
95% confidence interval for the indirect effect of coping indicated that coping was a mediator of 
the relationship between perceived stress and insulin initiation self-efficacy. 
The results of this study suggested assessment of stress and coping would be beneficial for 
patients initiating insulin therapy.  The RNAO BPG can be used by diabetes clinicians to initiate 
insulin therapy with structured education assisting patients to attain self-efficacy with insulin 
therapy with a decrease in their stress levels. 
Chapter 4, ‘Evaluating the Use of a Best Practice Guideline with Insulin Initiation in Type 2 
Diabetes’ 
The third article of this dissertation discusses patient recall of diabetes education with the use of 
the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
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and an evaluation tool that was developed for use with this BPG.  Best Practice Guidelines are 
becoming increasingly integrated into nursing care and provide a synthesis of research and 
clinical expertise.  Results are presented for Question #3, What is the level of participant recall of 
diabetes education using the RNAO BPG for the Subcutaneous Administration of Insulin in 
Adults with Type 2 Diabetes as evaluated by a novel BPG evaluation tool? and Question #4, 
What is the patient experience of initiating insulin therapy when receiving structured Best 
Practice Guideline diabetes education? 
The results of this study demonstrated effective provision of the RNAO BPG with participants 
recalling 80% of the BPG content.  Sick day management items, however, had a noticeably 
lower rate of recall at 27% – 62%.  This is an area for further research as the potential for 
significant patient harm can result during illness, for example, with poorly managed insulin 
dosing or if patients become severely dehydrated.  Lack of knowledge to self-manage routine 
illnesses may require patients to seek intervention from their primary care provider or in severe 
cases patients may need to access urgent care or emergency room assessment which has 
implications within the context of today’s fiscally challenged healthcare environment. 
The RNAO BPG evaluation tool developed for this study required the deletion of one item to 
yield a measurement scale with an acceptable internal consistency i.e. a Cronbach’s alpha of 
greater than or equal to 0.70. 
Content analysis performed on participant responses to three open-ended questions:  1. “Please 
describe how you felt when you were asked to start using insulin”, 2. “What was the most 
challenging thing about starting insulin?”, and 3.”What made it easier to start using insulin?” 
revealed three distinct categories of responses.  Consistent with the literature were responses 
related to the first category labeled as Psychological Insulin Resistance (PIR).  Participant 
responses identified the emotional elements related to insulin initiation such as fear of needles or 
injection, anxiety, or a belief that their diabetes is worsening.  The second category was labeled 
Knowledge Deficit and reflected participants’ misconceptions of current diabetes management.  
This has also been identified in the literature.  The last category was labeled Education Impact.  
Responses in this category supported the positive impact of the education they received which 
was guided by the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with 
Type 2 Diabetes. 
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1.7 Summary 
The final chapter presented in the thesis is an integrated summary of the research findings as 
identified in the three articles included in this dissertation.  The examination of the relationship 
between perceived stress and education guided by the RNAO BPG is reviewed.  The need for 
further research into the psychological assessment of patients initiating insulin therapy is 
discussed.  The development and utilization of the RNAO BPG evaluation tool are examined to 
assist with further revision of the tool for future use.  The results of the examination of the 
relationship between perceived stress, ways of coping and insulin initiation self-efficacy provide 
a foundation for continuing research to explore coping and stress in patients initiating insulin 
therapy.  The discussion includes patient focused assessment and exploration of educational 
strategies that best meet the needs of this unique patient population.  Implications for nursing and 
future research are reviewed.  
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Chapter 2 
2 Stress and Coping in Patients with Type 2 Diabetes          
Initiating Insulin:  A scoping review  
2.1 Introduction 
The global burden and incidence of type 2 diabetes is increasing precipitously in countries all 
over the world  (International Diabetes Federation, 2013).  In 2013, approximately 2.6 million 
Canadians were living with diabetes (type 1 or type 2).  The majority of people,  90 to 95% have 
type 2 diabetes which is a combination of insufficient insulin production and impaired response 
to insulin’s effects (insulin resistance) (Public Health Agency of Canada, 2011a).    (Despite 
healthcare provider efforts and the integration of clinical practice guidelines, approximately half 
of the Canadians living with type 2 diabetes do not achieve the glycemic target of  hemoglobin 
A1C  < 7.0%  (Harris, Ekoe, Zdanowicz, & Webster-Bogaert, 2005; Harris, Kapor, Lank, 
Willan, & Houston, 2010b; Leiter et al., 2013b). Optimal glycemic control is critical for the 
prevention or minimization of diabetes-related complications as demonstrated by the landmark 
United Kingdom Prospective Diabetes Study (United Kingdom Prospective Diabetes Strategy 
(UKPDS) Group, 1998).   Diabetes self-management education (SME) has been shown to 
provide clinically important benefits for patients with type 2 diabetes including hemoglobin A1C 
reductions (Jones, Berard, MacNeill, Whitham, & Yu, 2013).  With the number of people living 
with diabetes projected to rise significantly in the next 20 years, educating patients regarding 
self-management is critical to ensure their quality of life and avoidance of complications.  This is 
particularly relevant in a healthcare system where fiscal pressures are evident and economic 
burden of diabetes in Ontario in 2010 was 4.9 billion dollars (Canadian Diabetes Association, 
2013b). 
In order to achieve optimal glycemic control, many patients with type 2 diabetes will require 
insulin.  The use of insulin, which historically was often the last agent to be added to a patient’s 
treatment, is now considered at any stage of the diabetes continuum according to the Canadian 
Diabetes Association (CDA) Clinical Practice Guidelines based on the patient’s clinical 
presentation.  Barriers to insulin therapy such as psychological insulin resistance (PIR), diabetes 
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distress, and clinical inertia are well documented in the literature (Brod, Kongso, Lessard, & 
Christensen, 2009; Brown, Nichols, & Perry, 2004; Fisher et al., 2009; Gherman et al., 2011; 
Harris, et al., 2010a; Harris, Yale, Dempsey, & Gerstein, 2008; Paddison, Alpass, & Stephens, 
2007; Peyrot et al., 2005; Polonsky, 2007).  This presents a challenge for healthcare providers 
working with patients to help them to achieve optimal glycemic control and enhanced quality of 
life.  Recognizing that self-management education needs to be tailored to meet individual needs, 
it is imperative that healthcare providers have an understanding of patients’ perspectives of their 
diabetes and the factors influencing their abilities for diabetes self-management.  Only then can 
educational strategies and clinical practice guidelines fully reflect the holistic needs of patients 
and appropriately inform the healthcare providers working with these patients.  The purpose of 
this scoping review is to provide a descriptive account of available research and non-research 
material centring on the research gap associated with patients starting insulin therapy with type 2 
diabetes.   A scoping review was chosen for the ability to map the literature, sources of evidence, 
and gaps in the research particularly when “there is suspicion that not enough literature exists” 
and “further primary research is necessary” (CIHR, 2009). 
2.1 Method 
 A scoping review based on the framework proposed by Arksey and O’Malley (2005) was chosen for 
this article.  The framework identifies five stages with an optional consultation exercise:   
(1) Identifying the research question. 
(2) Identifying relevant studies. 
(3) Study selection. 
(4) Charting the data. 
(5) Collating, summarizing and reporting the results. 
(6) Optional consultation exercise  
Arksey and O’Malley suggest a common reason for the use of a scoping review includes 
identifying research gaps in the current literature which aligns well with this review.  Anderson, 
Allen, Peckham, and Goodwin (2008)  suggest policy mapping as a scoping review can identify 
main documents and statements from professional bodies that influence the nature of practice in 
that area.  This element was included in this scoping review to assist with guiding future 
educational strategies. 
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The research question for this review was “What is known about the relationship between 
perceived stress, ways of coping and the initiation of insulin therapy in adults with type 2 
diabetes?”  A policy mapping was also included as part of this review to examine the main 
documents and statements available that relate to the nature of practice in this area of diabetes.  
    In order to identify relevant literature, electronic database searches were performed in 
CINAHL, PubMed, PyschINFO, and ProQuest.  The main subject areas searched were diabetes, 
stress, coping, and diabetes health policy. Websites for organizations known to have a strong 
focus in diabetes care were searched directly for any policy or guideline statements.   As there is 
no worldwide common database for grey literature, the search strategy included primarily North 
American literature.  The focus of the search was based on type 2 diabetes particularly in relation 
to the initiation and the use of insulin.  For this review, stress was defined as the relationship 
between a person and the environment which affects the person’s well-being.  The definition of 
coping used for this review was the thoughts and behaviours used by a person to manage stress.   
Search terms used independently and then in combination included:  diabetes mellitus, type 2 
diabetes, diabetes self care, coping, ways of coping, stress, distress, psychological distress, 
insulin,  initiating insulin, starting insulin,  psychological insulin resistance.  Inclusion criteria for 
this scoping review were: (a) English language, (b) primary research, meta-analysis, literature 
review, and (c) published between 2001 and 2013.  Reference lists of selected items were hand 
searched for additional items eligible for inclusion in the review.  To complete the policy 
mapping review, a grey literature search of North American diabetes professional organizations 
and governmental bodies focused on diabetes clinical practice documents. 
    The selection process resulted in nine relevant items that most closely aligned with the 
research question and nine documents related to policy mapping.  It is important to remember 
that, unlike a systematic review, a scoping review can include a range of different methods and 
study designs and does not assess the quality of evidence, rather it provides a descriptive account 
of available research (Arksey & O'Malley, 2005).  Although there was an abundance of literature 
on the separate elements of the research question, stress or coping with type 2 diabetes or 
guidelines detailing suggested processes for initiating insulin, more difficult to find were articles 
which included all of the elements of the research question.  Few items were focused specifically 
on stress and ways coping at initiation of insulin therapy.   Charting the data for a scoping review 
involves extracting data using a “narrative review” method which presents contextual or process 
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oriented information from each item included in the review (Arksey & O'Malley, 2005; Levac, 
Colquhoun, & O'Brien, 2010).   The data from this review were organized along two thematic 
categories (a) Insulin initiation barriers and (b) Coping (Table 1).  The data from the policy 
mapping were charted according to the regional level of policy influence (Table 2).        
Table 1 Selected Scoping Review Items  
Author/Date/Country Method / Aim Sample Important Results 
Insulin Initiation Barriers 
 
Bogaten & Hancu 
2001 
Romania 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gherman et al., 
2011 
Romania 
 
 
 
Qualitative semi-
structured interviews 
with phenomenologic 
and content analysis 
Aims:  (1) Identify 
representations of 
insulin therapy, (2) 
study the factors 
influencing the 
representations, (3) 
study factors that 
might influence 
decision to 
accept/refuse 
treatment 
 
 
Critical Literature 
Review 
Aim:  Answer the 
questions:  How is 
PIR measured? With 
 
n = 18 people 
at the moment 
of initiating 
insulin therapy 
 
 
 
 
 
 
 
 
 
 
 
 
 
n = 60 varied 
articles  
 
 
 
 
Psychological Insulin Resistance 
(PIR)  influenced by the  
perceived  reasons for the need 
to start insulin therapy and the 
perceived  consequences of 
insulin therapy 
 
Patient attitudes regarding  
insulin therapy influenced by   
family, healthcare providers, 
others on insulin 
 
Physical discomfort is a  
determinant factor in  
acceptance/refusal of insulin 
therapy 
 
PIR consistent among insulin 
naïve patients with ~ 27% 
 refusing to initiate insulin 
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Polonsky, Hajos, 
Dain, Snoek 
2011 
U.S.A. 
 
 
 
 
 
 
 
 
 
 
 
 
Rubin, Peyrot, 
Kruger, Travis 
2009 
U.S.A.  
 
 
 
 
what instruments?  
Predictive factors? 
Interventions 
proposed to reduce 
PIR? 
 
 
Internet survey  
Aim:  Assess 
willingness to start 
insulin, insulin 
beliefs, current 
medications, diabetes 
distress 
 
 
 
 
 
 
 
 
 
Internet surveys 
Provider survey  
(physicians, diabetes 
educators) 
Patient self-report 
Aim: Compare 
patients’ perceptions 
of injection-related 
 
 
 
 
 
 
 
n = 1400 
insulin-naïve 
patients with 
type 2 diabetes 
in 8 Western 
nations 
 
 
 
 
 
 
 
 
 
 
Provider 
sample 
 n = 301 
Patient sample 
n = 501 with 
77% of 
patients having 
type 2 diabetes 
Emotional state, lack of  
knowledge, low self-efficacy  
predictors of PIR 
 
Relationship with healthcare 
providers influences PIR 
 
Presence of PIR common across 
the 8 Western nations with     
17.2% unwilling to and 34.7% 
 ambivalent about starting  
 insulin 
 
Patients unwilling or ambivalent  
to start insulin reported more  
diabetes-related emotional  
distress 
 
Authors suggest most effective  
approach to PIR involves  
addressing patients’ emotional 
distress 
  
Reported several findings 
related to the burden of insulin  
injections e.g. 46% patients  
have changed their life to avoid 
extra injections 
 
Moderate or major impact of  
 insulin injections on quality of 
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Wang & Yeh 
2012 
Taiwan 
 
problems with 
clinicians’ estimates 
of those problems 
 
 
 
 
 
Mixed-methods 
systematic review 
Aim: Describe the 
phenomenon of PIR 
from the perspective 
of adults with type 2 
diabetes 
 
 
 
 
 
 
 
 
n = 16 studies 
with 7961 total 
participants 
 life reported by 14% of  
 patients 
 
Healthcare providers report  
highest impact of problems for  
adherence to injections related 
to anxiety 
 
15 descriptive themes – 3 of  
which focused on participants’ 
choices of how to cope 5 main 
theme categories with two levels 
– cognitive appraisal and 
emotional responses 
Coping 
Gafvels & Wandell 
2005 
Sweden 
 
 
 
 
 
Karlsen, Oftedal, 
Bru 
2012 
Norway 
 
 
 
Cross sectional design 
– self-report coping 
questionnaire; chart 
review 
Aim: Assess and 
compare coping 
strategies in patients 
with type 2 diabetes  
 
Cross sectional design 
- questionnaires 
Aim: Describe 
diabetes-related 
distress, coping styles, 
perceptions of social 
support among adults 
n = 232 
patients ~ 30% 
on insulin 
 
 
 
 
 
n = 378 adults 
with 28.6% on 
insulin 
 
 
 
 
Coping strategies clearly  
associated with metabolic  
control. 
Variations in coping strategies  
between men and women. 
Coping a good predictor for  
HbA1C and microangiopathy. 
 
One fifth of participants  
experienced relatively high  
levels of diabetes-related  
distress 
Greater variance in emotional  
distress accounted for by  
coping styles and perceived  
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Macrodimitris & 
Endler 
2001 
Canada 
 
 
 
 
 
 
Shah et al. 
2012 
U.S.A. 
with type 2 diabetes 
 
 
 
 
 
 
 
 
Cross-sectional design 
- 4 measures 
Aim: determine 
relationships among 
coping, illness 
control, psychological 
adjustment 
 
 
 
Cross-sectional design 
using cognitive and 
behavioural coping 
strategy instrument 
and a screening tool 
for depression 
Aim: Examine the 
relationship among 
diabetes-related 
distress, appraisal, 
coping and depressive 
symptoms 
 
 
 
 
 
 
 
 
 
n = 115 adults 
with 18.3% on 
insulin 
 
 
 
 
 
 
 
n = 201 adults 
with 35.3% on 
insulin 
support versus clinical  
 indicators 
 
Healthcare providers should  
develop methods to decrease  
diabetes-related distress that  
prevent the use of negative  
coping styles 
 
Problem-focused coping related  
to better psychological  
adjustment 
 
Emotional preoccupied coping  
and avoidance coping related 
to poor psychological  
adjustment 
 
 
Patients who experienced 
greater diabetes-related stress 
had a negative appraisal of their  
diabetes and were less likely to 
use problem-focused coping 
 
Emotions and coping play a 
central role in the    
diabetes/depressive symptom  
relationship 
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2.2 Results 
Arksey and O’Malley (2005) describe the fifth stage of the scoping framework as collating, 
summarizing and reporting the results.  The following overview describes the two themes 
identified within this scoping review and the results of the policy mapping.  The results are 
divided into three subsections.  The two themes identified were (1) insulin initiation barriers, and 
(2) coping.  The final subsection describes the results from (3) policy mapping. 
2.2.1  Insulin Initiation Barriers 
Five of the articles selected for this scoping review reflected the theme identified as “insulin 
initiation barriers”, given that the majority of literature examines issues that impede insulin 
initiation.  Psychological insulin resistance (PIR) is the dominant concept throughout this area of 
the literature and is most often defined as a psychological (cognitive, emotional, relational, and 
cultural)  barrier or opposition to the initiation of insulin (Brod, et al., 2009).  Diabetes-related 
distress is also found within this theme and is defined as the disease specific stress related to the 
burden of self-care management of diabetes.  The articles selected included one qualitative study, 
one literature review, two internet surveys and a mixed-methods systematic review.    
     Bogatean and Hancu (2001) conducted a qualitative study using semi-structured interviews 
with 18 participants (11 men, 7 women) at the moment of initiating insulin.  A phenomenologic 
analysis and content analysis revealed that psychological insulin resistance is influenced by the 
perceived reasons of the need to start insulin and the perceived consequences of insulin therapy.  
Findings also revealed that attitudes regarding insulin therapy are influenced by family, other 
people on insulin, and the healthcare team.   
     Gherman et al. (2011) performed a critical literature review of psychological insulin 
resistance (PIR) and the strategies to reduce it.  Databases were searched ultimately yielding 60 
articles of varying types   (reviews, editorials, cross-sectional studies, instrument validation) that 
were summarized in the meta-analysis.  Six instruments were found that investigated the 
emotional distress related to insulin, positive/negative insulin expectations, or satisfaction with 
consequences on daily activities.  The authors found that the number of patients with PIR in 
research settings versus community settings is consistent at approximately 27%.    Themes 
revealed emotional states influenced PIR, as well as, cognitive predictors, e.g., lack of 
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knowledge.  Healthcare providers were found to have an influence on a patient’s perception of 
requiring insulin.  
In a multi-national study to examine the perceptions of insulin-naïve type 2 diabetes patients, 
Polonsky, Hajos, Dain and Snoek (2011) found the presence of psychological insulin resistance 
(PIR) to be common.  Participants originated from France, Germany, the United Kingdom, Italy, 
the Netherlands, Spain, Sweden, and the U.S.A. with a sample size of 1400.   Qualitative 
interviews were conducted to develop survey tools assessing beliefs about insulin, beliefs about 
current oral medications, and diabetes-related distress.  Findings showed patients unwilling or 
ambivalent to start insulin reported more diabetes-related emotional distress replicating results 
from previous studies (Makine et al., 2009; Snoeks, Skovlund, & Pouwer, 2007).  The authors 
suggest the most effective approach overall to overcoming or preventing PIR includes addressing 
emotional distress about living with diabetes, worries about diabetes medicines and patients’ 
specific beliefs about insulin. 
Barriers to injection therapy were compared in a study by Rubin, Peyrot, Kruger, and Luther 
(2009). They described the (1) burden of insulin injections, (2) impact of injections on quality of 
life, (3)  impact of injection therapy on treatment adherence, (4) injection-related patient/provider 
communication, and (5) tools to ease burden of insulin injections.   Overall, a substantial 
majority of patients wanted to reduce the number of injections they took on a daily basis.  More 
than half of the patients indicated that they were more likely to take their insulin injections if a 
product was available to ease the pain of injection. 
In a mixed-method systematic review of psychological insulin resistance (PIR) in adults with 
type 2 diabetes the authors concluded that there is impact from a range of cognitive and/or 
emotional reaction personal viewpoints (Wang & Yeh, 2012).  The review question was “What is 
known about the psychological barriers to starting insulin therapy among adults with T2DM 
when or if their physicians recommend they use insulin therapy?”  The sixteen articles reviewed 
originated from sixteen developed countries with participants from Europe, Asia, Australia, and 
North America.  Seven of the studies were interview models, five were descriptive studies and 
four performed psychometric analyses of data related barriers to insulin initiation.  The five main 
themes reported that people with type 2 diabetes (1) do not see the necessity for insulin and 
actively seek ways to control blood sugars without insulin, (2) have a holistic view of the 
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consequences of insulin, (3) see insulin therapy as less feasible, (4) see insulin as a source of 
fear/anxiety, and (5) feel the necessity to start insulin therapy has a very negative connotation 
and is associated with dysfunctional emotions.  The authors concluded that psychological 
resistance to insulin therapy involved cognitive appraisal and emotional reaction requiring 
assessment of an individual’s psychosocial barriers to insulin therapy. 
2.2.2  Coping 
Four cross-sectional studies were identified in the second theme identified as coping.  Gafvels 
and Wandell (2006) conducted a cross-sectional study assessing coping strategies with a 
Swedish, non-illness specific, self-report questionnaire measuring cognitive, emotional, and 
action-orient coping efforts.  Demographic data was collected from medical records and data on 
social and psycho-social background were taken from a previous study.  Main study findings 
reported a clear association between coping strategies and metabolic processes.  Differences in 
coping strategies found women using negative coping methods (resignation, protest, isolation) 
more often than men.   Coping was found to be a good predictor for hemoglobin A1C and 
microangiopathy in insulin treated patients.   
     The study that most reflected the research question of this scoping review was conducted by 
Karlsen, Oftedal and Bru (2012).  The cross-sectional design employed questionnaires to 
investigate clinical indicators (hemogloblin A1C, complications, BMI, disease duration), coping 
styles, and perceived support from healthcare professionals and family related to diabetes-related 
distress.  Of 689 participants invited to participate, a final sample size of 378 was obtained.   The 
Problem Areas in Diabetes (PAID) instrument was utilized to assess diabetes emotional distress, 
sub-scales from the COPE Inventory and Ways of Coping Questionnaire assessed coping styles.  
The Patient Questionnaire on Empowerment assessed support from healthcare providers, while 
the Diabetes Family Behaviour Checklist assessed family behaviours.  The authors reported that 
one-fifth of the participants reported severe diabetes-related distress which was consistent with 
previous research  (Fisher, et al., 2009).  Also consistent with previous research, was the finding 
that showed greater use of task-oriented coping more than emotion-focused coping.  Participants 
felt they received constructive support to a much greater degree from healthcare providers (76%) 
than their families (11%).   The regression analysis showed a substantially greater variance in 
emotional distress accounted for by coping styles and perceived support versus clinical 
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indicators.  The authors suggested that healthcare providers should develop methods to decrease 
diabetes-related distress that prevent the use of negative coping styles. 
The only Canadian study selected for this scoping review was a cross-sectional design 
investigating the relationships of coping strategies and perceived control to psychological and 
physiological adjustment in adults with type 2 diabetes (Macrodimitris & Endler, 2001).   
Separate instruments were used to assess the following variables (1) coping, (2) perceived 
control, (3) anxiety, (4) depression, and (5) hemoglobin A1C.  Findings indicated that problem-
focused coping strategies were related to better psychological adjustment, while in contrast, 
emotional coping and avoidance coping were related to higher depression and state anxiety.   
Perceived control was determined to have a direct negative relationship to depression, state 
anxiety and hemoglobin A1C.  The authors suggested that high levels of perceived control have a 
favourable effect on adjustment in people with type 2 diabetes.   
The relationship between diabetes-related distress, appraisal, coping and depressive symptoms in 
adults with type 2 diabetes was examined in the context of the transactional model of stress and 
coping by Shah, Gupchup, Borrego, Raisch, and Knapp (2012).  A sample of 201 participants 
completed the cross-sectional study which utilized surveys and a medical records chart review.   
Findings revealed that participants with depressive symptoms reported significantly higher levels 
of diabetes-related stress than patients without depressive symptoms.   Findings also suggested 
that appraisal was a mediator in the relationship between stress and coping.  Appraisal also 
mediated the relationship between depressive symptoms and the coping measures of avoidance, 
passive resignation, and diabetes integration.  The authors suggest emotions and coping play a 
central role in the relationship between diabetes and depressive symptoms and that interventions 
that promote stress management and healthy coping may assist patients to adapt to living with 
diabetes.      
2.3  Policy Mapping 
     The policy mapping element of this scoping review focused on the main documents and 
statements from professional bodies that influence the nature of clinical practice in diabetes.  The 
nine documents published in English selected for this scoping review originated from developed 
countries that possess the resources and expertise to provide diabetes care at a similar level.  The 
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countries represented within this policy mapping review are congruent with the sources of items 
selected for the previous section related to the research question scoping review.   Six of the 
documents are directed at healthcare providers with evidence-based clinical practice guidelines 
to direct care of individuals with type 2 diabetes (American Diabetes Association, 2014; 
Canadian Diabetes Association, 2013a; International Diabetes Federation, 2012; National 
Collaborating Centre for Chronic Conditions, 2008; Registered Nurses Association of Ontario, 
2009; Ryden et al., 2013).   Practice guidelines directed at diabetes educators provide guidance 
for the training of diabetes educators and diabetes educational practice in the United States 
(American Association of Diabetes Educators, 2011)  The National Service Framework for 
Diabetes (Department of Health (United Kingdom), 2001) was developed to provide direction 
for diabetes care in health sector service planning in the United Kingdom.  Similarly, The 
Diabetes in Canada (2011) document is a statistical resource to support public health 
professionals and organizations in the development of evidence-based public health policies and 
programs in the prevention and management of diabetes.  The policy mapping documents are 
summarized in Table 2. 
 
 
Table 2 Policy Mapping Results 
Source/Year Policy 
Influence 
Level 
Document Summary 
American Association of 
Diabetes Educators 
(AADE) 
2011 
National Guidelines for the Practice 
of Diabetes Self-
Management Education 
and Training  
Clarifies the roles and 
responsibilities of all 
persons facilitating 
diabetes education 
American Diabetes 
Association 
(ADA) 
2014 
National Clinical Practice 
Recommendations  
Evidence-based 
clinical practice 
recommendations to 
be interpreted on an 
individual basis 
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Canadian Diabetes 
Association 
(CDA) 
2013 
National / 
International 
Clinical Practice 
Guidelines for the 
Prevention and 
Management of Diabetes 
in Canada  
Chapters 1, 7 , 9, 13 
Provides evidence-
based 
recommendations on 
screening, prevention, 
diagnosis, education, 
care and management 
of diabetes. 
Department of Health 
(United Kingdom) 
2001 
National National Service 
Framework for Diabetes: 
Standards 
 
Standards, rationales, 
key interventions, 
implications for 
planning services 
 
European Association 
for the Study of Diabetes 
(EASD) in collaboration 
with European Society 
of Cardiology (ESC) 
2013 
International ESC Guidelines on 
diabetes, pre-diabetes, and 
cardiovascular diseases 
developed in collaboration 
with the EASD 
 
Guidelines provide 
educational tool with 
evidence-based 
approaches and 
algorithms for 
achieving best care in 
managing the 
combination of 
diabetes and 
cardiovascular disease 
International Diabetes 
Federation  
(IDF) 
2012 
 
 
 
International Global Guideline for Type 
2 Diabetes  
Clinical practice 
guideline sensitive to  
resource and cost-
effectiveness issues 
for countries with 
limited resources 
(expertise, financially) 
 
National Institute for National Type 2 Diabetes Clinical, evidence-
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Health and Clinical 
Excellence (NICE) 
(England and Wales) 
2008 
National clinical guideline 
for management in 
primary and secondary 
care  
based guidelines 
intended for 
healthcare 
professionals, people 
with type 2 diabetes 
and their support 
systems  
Registered Nurses 
Association of Ontario 
(RNAO) 
2007-2013 
Provincial / 
National 
Best Practice Guidelines  
directed at diabetes 
(a)Subcutaneous 
Administration of Insulin 
in Adults with Type 2 
Diabetes 2009 
(b)Assessment and 
Management of Foot 
Ulcers for People with 
Diabetes 2013 
(c) Reducing Foot 
Complications for People 
with Diabetes 2007 
Provides resources 
necessary for the 
support of evidence-
based nursing practice 
in the provision of 
individualized care. 
 
Provides overview of 
structures and 
supports necessary for 
provision of best 
possible evidence-
based care 
Public Health Agency of 
Canada 
2011 
National Diabetes in Canada: Facts 
and figures from a public 
health perspective  2011 
Provides most recent 
diabetes statistics in 
Canada.  Offers risk 
factors for developing 
diabetes 
 
 
2.4  Discussion 
     The findings from this scoping review reinforce the need for continued research exploring the 
psychological aspects of diabetes care which is integral to helping patients improve their diabetes 
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self-management and ultimately their glycemic control.   Despite the availability of extensive 
clinical practice resources, new pharmacologic agents, and an increased awareness of the 
psychosocial needs of patients with diabetes, the majority of patients do not reach target 
glycemic control (Nam, Chesla, Stotts, Kroon, & Janson, 2011; Nicolucci et al., 2013a; Piya, 
Tahrani, & Barnett, 2010).  In a recent follow-up to a major research study exploring the 
Diabetes Attitudes, Wishes, and Needs (DAWN) of people with diabetes, the need for 
psychosocial support and individualized education was once again reinforced (Holt et al., 2013; 
Nicolucci et al., 2013b; Peyrot, et al., 2005).  The two themes identified in this scoping review:  
(a) insulin initiation barriers and (b) coping, elucidate the importance of examining these 
concepts from the individual’s perspective.  It is critical that healthcare providers design and 
deliver educational supports that will meet the needs of the individual. 
Foundational research exists which examines the barriers to insulin initiation.  Numerous factors 
have been identified from both the patient and healthcare provider perspectives.  These factors 
include psychological insulin resistance, diabetes distress, fear of injection therapy, and clinical 
inertia.  As Wang and Yeh (2012) suggest, technique-oriented skills training or endeavouring to 
convince individuals to initiate insulin therapy, may meet the needs of the healthcare provider 
but not those of the individual.  They further suggest, “It is essential to have knowledge of how 
people arrive at medical decisions in relation to their perception of the illness, before we can 
guide people’s  awareness of the need for insulin therapy” (p. 754).  Previous research (Bogatean 
& Hancu, 2001) reported patient attitudes regarding insulin are influenced by their family, others 
on insulin, and healthcare providers which means that the opportunity to educate and influence 
patients exists.  The key is for healthcare providers to use their opportunity to educate in a way 
that is meaningful for the patient.  With the research by Polonsky, Hajos, Dain and Snoek (2011) 
demonstrating that psychological insulin resistance (PIR) is a common phenomenon, both 
researchers and educators should heed the authors’ suggestion that the most effective approach to 
decrease PIR is by addressing patients’ emotional distress.   
Mirroring the need for further research regarding stress and distress, the concept of coping 
continues to receive increasing focus. The findings of Gafvels and Wandell(2006) linking coping 
strategies to glycemic control reiterated the link between the psychological and biophysical 
aspects of diabetes.  Shah et al. (2012) concluded that the knowledge that patients with high 
stress levels are likely to develop a negative appraisal of their diabetes, should assist educators to 
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develop programs for those at high risk.  They also assert that stress management training could 
be incorporated in diabetes education programs.   This reinforces the need for individualized 
patient assessment with a goal of comprehensive, holistic care.      
Research has established that patients employ varying coping styles.  Coping styles such as 
behavioural disengagement and self-blaming are linked significantly with emotional distress 
(Karlsen, et al., 2012) (Canadian Diabetes Association, 2013c).  For those patients who have 
difficulty with their diabetes self-management, an understanding of their coping styles could 
assist healthcare providers when choosing educational strategies and processes for providing 
care.  
Comprehensive practice guidelines and policy frameworks are available as evidence-based 
resources in diabetes.  As the research evidence continues to accumulate regarding the 
importance of the psychological aspects of diabetes care, it is encouraging that diabetes 
professional organizations and makers of health policy are integrating these elements into the 
practice guidelines and frameworks that guide diabetes care.  Chapters addressing the 
psychological care of individuals with diabetes can be found in the clinical practice guidelines 
from Canada, United States, United Kingdom, Europe and the International Diabetes Federation.   
The documents selected within the policy mapping for this scoping review, consistently 
identified the need to provide comprehensive diabetes care while acknowledging that continued 
research is required.  Although the need for psychological support is articulated in practice 
guidelines, knowledge translation is sub-optimal as gaps persist in our understanding of patient 
perceptions of diabetes and their ways of coping. 
2.5  Conclusion 
This scoping review highlights the paucity of knowledge available to inform healthcare providers 
of the patient’s perception of stress and coping with the initiation of insulin therapy and therefore 
a gap in research knowledge. (Figure 2) Evidence continues to mount highlighting the 
importance of addressing these psychological aspects of diabetes care.  The challenge to 
researchers and healthcare providers is to identify these influencing factors and incorporate 
educational strategies that acknowledge these factors.  Patient-specific education strategies 
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recognizes the unique challenges that each patient faces and may  assist patients to meet their 
goals of self- care with the hopes of improving glycemic control and enhancing quality of life. 
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Chapter 3 
3. Coping as a Mediator of Stress with the Initiation of Insulin in 
Type 2 Diabetes  
3.1  Introduction 
Type 2 diabetes affects approximately 90% of those who live with diabetes (Centre for Disease 
Control and Prevention, 2014; Government of Canada, 2013) .  In Canada, an estimated 2.6 
million people live with this disease and in every age group, individuals with diabetes have 
mortality rates at least two times higher than those without diabetes (Public Health Agency of 
Canada, 2011b).  For a chronic, progressive disease, the focus of diabetes patient education is to 
provide the knowledge and skills that will allow patients to self-manage their condition and 
minimize the potentially devastating complications of diabetes.  People living with diabetes are 
at increased risk for  macrovascular complications (myocardial infarction and stroke) and 
microvascular complications (retinopathy, nephropathy, neuropathy) (Chalmers & Cooper, 2008; 
Lasker, 1993; United Kingdom Prospective Diabetes Strategy (UKPDS) Group, 1998). Glycemic 
targets and clinical practice guidelines for the management of diabetes continue to evolve as 
research demonstrates the importance of optimal glycemic control (Chalmers & Cooper, 2008; 
Holman, Paul, Bethel, Matthews, & Neil, 2008; United Kingdom Prospective Diabetes Strategy 
(UKPDS) Group, 1998).   The 2013 Canadian Diabetes Association Clinical Practice Guidelines 
emphasized the importance of achieving optimal glycemic control within 3 to 6 months once 
pharmacologic therapy has been initiated.  The guidelines also suggest that patients with marked 
hyperglycemia may benefit from the initiation of insulin as a first line intervention in addition to 
oral agents (Harper et al., 2013). 
Clinical practice has historically reserved the use insulin as one of the final agents to be added to 
a patient’s pharmacologic regimen.  This hesitation may be in part related to the phenomenon 
known as psychological insulin resistance (PIR).  Psychological insulin resistance is most often 
defined as a psychological barrier or opposition to the initiation of insulin (Brod, et al., 2009; 
Gherman, et al., 2011; Polonsky, 2007).  PIR is well documented in the literature and is found 
within both patients and healthcare providers.  Patients are reluctant to start or fear beginning 
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insulin therapy and clinicians are reluctant to initiate insulin therapy. The reluctance by clinicians 
to initiate insulin therapy is more specifically termed “clinical inertia” (Brown, et al., 2004; 
Harris, et al., 2010b; Harris, et al., 2008; Phillips et al., 2001). Unfortunately, delaying the 
introduction of insulin has sometimes been leveraged by healthcare providers as a motivator for 
patients to improve their adherence to lifestyle and dietary changes reinforcing the idea that 
insulin should be left as the last resort.  This “treatment to failure” approach – adding multiple 
oral agents with insulin as the final option- is challenged in the literature as unnecessarily 
prolonging an uncontrolled hyperglycemic state in patients predisposing them to the 
microvascular and macrovascular complications of diabetes (DeFronzo, Eldor, & Abdul-Ghani, 
2013; Lingvay et al., 2009).   
3.1.2  Stress and Diabetes 
The psychosocial aspects of living with diabetes are well recognized (Clement, et al., 2013; 
Jones, et al., 2013; Nicolucci, et al., 2013b; Peyrot, et al., 2005; Skovlund & Peyrot, 2005).  
Managing diet and exercise, self-monitoring of blood glucose, and adhering to medication 
regimens on a daily basis often create a heavy burden for those living with diabetes.  Diabetes 
distress describes the disease-specific stress related to this burden of diabetes self-care 
management.  The challenges with the identification and treatment of diabetes distress are also 
well described in the literature (Fisher, et al., 2009; Paddison, et al., 2007; Peyrot, Rubin, & 
Siminerio, 2006).  Research also points to the reduction of general life stress and consideration 
of broader life contextual factors as influential elements of diabetes management (Albright, 
Parchman, & Burge, 2001; Fisher, et al., 2009).  It is important to remember that 95% of diabetes 
care is done by the individual themselves (Funnell & Anderson, 2000).  Given the small 
percentage of time interacting directly with health care providers, it is important to ensure that 
educational opportunities meet the needs of the  individual and support behavioural change, as 
well as, knowledge transfer.  When designing healthcare education or directly providing patient-
focused  education, health care providers need to be sensitive to individual differences in how 
patients appraise, explain, and cope with stressors which are likely to influence a patient’s ability 
to comprehend and retain new knowledge  (Roesch, Weiner, & Vaughn, 2002). 
 
35 
 
 
 
3.1.3  Coping and Diabetes  
The need to behaviourally regulate metabolic processes that are normally controlled by 
autonomic physiologic functioning makes coping with diabetes different from other chronic 
illness (Karlsen & Bru, 2002).  People living with diabetes must control the timing, quality and 
quantity of their nutritional intake and optimize their activity and exercise levels to achieve the 
targets set for optimal metabolic glycemic control.  Coping with diabetes is a lifelong necessity 
and impacts on the health outcomes achieved by self-management.  Gafvels and Wandell (2006) 
assessed coping strategies in adults with type 2 diabetes and found a clear association between 
coping and metabolic control.  Research examining psychosocial factors predictive of 
relationships with self-care behaviour found coping efficacy uniquely accounted for  9% of the 
variance in self-care behaviour (Hart & Grindel, 2010).  Bandura notes that a person’s beliefs in 
personal self-efficacy or coping can affect life choices, vulnerability to stress and their quality of 
life functioning (1994).  For health care providers caring for patients with diabetes it is essential 
to have an understanding of the patient’s perception of their stress and their ways of coping with 
it.  Rubin and Peyrot (1999) suggested that with training, effective coping skills for diabetes self-
management can be developed and enhanced.   
 
3.1.4  Education Strategies 
The use of  interprofessional team-based diabetes care, which includes diabetes nurse educators, 
is well documented in the literature and promoted as the standard of care (Bodenheimer, Wagner, 
& Grumbach, 2002; Grimmer-Somers, Dolejs, Atkinson, & Worley, 2008; Phelps et al., 2009; 
Ritholz et al., 2011; Zwar et al., 2007).  This type of care has also been shown to improve 
glycemic control (Earles et al., 2001; Polonsky, 2003).   Effective diabetes education is therefore 
a key element of living well with diabetes.  The Canadian Diabetes Association (CDA) defines 
diabetes self-management education as “a systematic intervention that involves active patient 
participation in the self-monitoring (physiological processes) and/or decision making 
(managing)” (Jones, et al., 2013, p. 26).   The majority of diabetes management (~80%) occurs in 
the primary care setting which may influence the resources available to provide diabetes 
education (Borgermans et al., 2009).  In order for patients to fully participate in their educational 
opportunities, assessment of their stress levels and coping processes provides educators with 
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understandings to meet the individual needs of patients.  It has also been shown that behavioural 
interventions enhance education knowledge achieving longer term change in self-care behaviour 
(M. J. Davies et al., 2008; Kulzer, Hermanns, Reinhecker, & Haak, 2007; Minet, Moller, Vach, 
Wagner, & Henriksen, 2010).   
3.2  Registered Nurses Association of Ontario Best Practice   
Guidelines (RNAO BPG) 
The RNAO BPG development is a rigorous process which includes a systematic literature review 
and expert clinician and stakeholder consultation to provide evidenced-based recommendations 
in four areas consisting of (a) practice, (b) education, (c) organization and policy, and (d) 
evaluation and monitoring. The RNAO BPG for the Subcutaneous Administration of Insulin in 
Adults with Type 2 Diabetes provides nine specific recommendations that focus on the essential 
knowledge that a person requires to safely self-administer insulin (Appendix B). The RNAO 
BPG is designed to assist nurses and allied health professionals who are not specialists in 
diabetes care to assist clients to safely initiate and administer insulin (Registered Nurses 
Association of Ontario, 2009).   
3.3  Research Purpose 
The purpose of this research was to examine the relationships between perceived stress and ways 
of coping in patients with type 2 diabetes who initiated insulin therapy and received education 
guided by the Registered Nurses Association of Ontario (RNAO) Best Practice Guideline (BPG) 
for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes.  The two 
research questions were: 
 
1.  What is the relationship between perceived stress and education guided by the RNAO 
BPG for Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes? 
2. What is the relationship between perceived stress, ways of coping and the initiation of 
insulin therapy in adults with Type 2 diabetes?   
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3.4  Theory to Frame this Study 
Lazarus and Folkman (1984) presented the cognitive theory of stress and coping, a framework 
for examining psychological stress.  The theory holds that stress is contextual, an interaction 
between the person and his/her environment.  Folkman (1997) further revised the model to 
include positive psychological states.   Stress, as defined by Lazarus and Folkman and the 
definition used for this study, is “a relationship between the person and the environment that is 
appraised by the person as taxing or exceeding his or her resources and endangering his or her 
well-being” (1984, p. 21).  Two concepts are central to the theory (a) appraisal and (b) coping.  
Both appraisal and coping are influenced by an individual’s personal characteristics and the 
environment and are therefore considered to have stable and variable aspects.  Appraisal relates 
to a person’s “evaluation of the personal significance of a given event and the adequacy of the 
individual’s resources for coping” (Folkman & Greer, 2000, p. 12).  Coping is described as a 
dynamic system which is highly interactive (Folkman, 2010).  Coping refers to the thoughts and 
behaviors used by an individual and is subdivided into three types (a) emotion-focused coping 
centered on regulating distress, (b) problem-based coping centered on managing the problem 
causing distress and (c) meaning-based coping centered on the ability to maintain positive well-
being.  In this study, coping was proposed as a mediator of perceived stress and the patient’s 
self-efficacy with the initiation of insulin.  Lazarus and Folkman suggest that coping is a 
mediator that changes the relationship between the antecedent variable (perceived stress) and the 
outcome variable (insulin self-efficacy) transforming the original appraisal and attendant 
emotion.  According to Lazarus, “coping and the appraisals that influence it mediate any 
emotions that are generated by the emotions process” (2006, p. 10).   
Based on the theoretical model and examination of the literature, the following hypotheses for 
this study were developed (Figure 3):   
(1) Effective provision of  RNAO BPG for the Subcutaneous Administration of Insulin in Adults 
with Type 2 Diabetes will assist with decreasing patients’ perceived stress. 
(2) Patients with higher levels of perceived stress will have lower confidence in administering 
insulin and managing diet (insulin initiation self-efficacy). 
(3) Patients with higher perceived stress will engage more frequently in ways of coping. 
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(4) Patients with effective ways of coping will have higher confidence in administering insulin 
and managing diet (insulin initiation self-efficacy). 
(5) Coping (ways of coping) is a mediating variable of the perceived stress and initiation of 
insulin relationship. 
 
 
3.5  Methods 
3.5.1 Design and Sample 
A one-group, non-experimental pretest / posttest design was undertaken drawing a sample from 
patients who were seen at a Diabetes Education Centre (DEC) in Southwestern Ontario.  Ethics 
approval was obtained from the Western University Health Science Research Ethics Board and 
the hospital ethics boards for each of the involved DECs.  Participants were surveyed 
immediately prior to their first visit at a DEC for education prior to starting insulin and once 
again at their follow-up appointment approximately six weeks later.  Appointments in the DEC 
to start insulin were booked as one to one appointments with a nurse or dietitian and ranged from 
45 to 90 minutes.  Each participant completed the three survey tools prior to initiating insulin 
therapy and the same three tools at their follow-up appointment.  Additionally, a Best Practice 
Guideline evaluation tool developed for this study was administered during a brief interview 
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following the second appointment to evaluate the participants’ perceptions of the educational 
content reviewed during their appointments.  In order to be eligible for the study, participants 
needed to read and speak English, be over 18 years of age and be insulin naïve with no previous 
injection therapy experience with any type of injectable treatment. 
The final sample was obtained from three independent DECs (n =105). After initially recruiting 
113 participants, 4 participants did not return for their second visit and 4 participants were no 
longer using insulin at their second appointment.  The final study sample (Table 3) consisted of 
58 men and 47 women with a mean age of 62 years (range 25 – 86 years).  The majority of 
participants were married (68%).  The average duration of disease with diabetes ranged from 
newly diagnosed to 36 years with a mean of 11.6 years.  The majority of participants (80%) were 
started on once daily (basal) injections with the remainder on Multiple Daily Injections (MDI).  
Seventy per cent of participants had completed high school (42%) or college (28%).   
Table 3.  Demographics of final sample (n = 105) 
 
Demographic Frequency % 
Sex 
     Female 
     Male 
Marital Status 
     Single 
     Married  
     Divorced/Separated 
     Widowed 
Education 
     Elementary School 
     High School 
     College 
     University 
Insulin Regimen 
     Basal (Once daily) 
 
47 
58 
 
6 
71 
21 
7 
 
11 
44 
30 
19 
 
84 
 
45 
55 
 
6 
68 
20 
7 
 
11 
42 
28 
18 
 
80 
40 
 
 
 
     Multiple Daily Injections 21 20 
 range          mean          SD 
Age (yrs) 
Duration with Diabetes (yrs) 
25-86            62          10.73 
  0-36          11.6          7.74 
 
3.5.2  Measures 
Demographic data collected to describe the study sample included sex, age, duration of diabetes, 
education level completed, marital status, and type of insulin program initiated.   
The Perceived Stress Scale (PSS) was used to measure participants’ stress levels (Cohen, et al., 
1983).  The 10 item PSS is a self-report global stress measure using a 5 point Likert scale 
ranging from 0 (never) to 4 (Very Often).  The total perceived stress score is calculated by 
summing all 10 items of the scale (items 4, 5, 7, 8 are reversed scored) with a possible range of 0 
to 40.  Higher scores reflect higher levels of perceived stress.  The reported reliabilities of the 
PSS demonstrate Cronbach’s alpha ranges from 0.75 to 0.91 (Reis, Hino, & Rodrigues-Anez, 
2010).  The Cronbach’s alpha reliabilities in this study were 0.83 (pre) and 0.82 (post).   
The Ways of Coping Questionnaire (WAYS) was used in this study to measure the theoretically 
derived coping relationship between stress and the participant’s self-efficacy with insulin 
therapy.  It was designed to identify coping processes – thoughts and actions that an individual 
uses to cope with a specific stressful encounter (Folkman & Lazarus, 1988).  The WAYS is a 66 
item self-report questionnaire with 8 subscales measuring coping processes The 8 coping 
subscales include (a) Confrontive Coping, (b) Distancing, (c) Self-Controlling, (d) Seeking 
Social Support, (e) Accepting Responsibility, (f) Escape-Avoidance, (g) Planful Problem 
Solving, and (h) Positive Reappraisal.  Items from the 4 point Likert scale were summed, the 
higher the score the greater use of a particular coping process.  The Cronbach’s alpha reported 
for the 8 subscales range from 0.61 to 0.79.  In this study, the Cronbach’s alphas were consistent 
with previously reported values for each scale with a range of 0.59 to 0.82 (pre) and 0.67 to 0.77 
(post).  Raw scoring was used in the final analysis, summing the scores from each of the 
subscales which provided a total score.  The total coping score reflected the extent to which each 
type of coping was used in each encounter.  
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The Confidence in Administering Insulin and Managing Diet Scale (CAI-MDS) was developed 
by the Nursing Best Practice Research Unit in partnership with the Registered Nurses 
Association of Ontario (RNAO) to evaluate patient outcomes with the use of the RNAO Best 
Practice Guideline on Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
(Registered Nurses Association of Ontario, 2009).  It is a measure of self-efficacy and contains 
21 self-report items with 2 subscales: a 12 item insulin administration scale and 9 item managing 
diet scale.  Cronbach’s alpha for the insulin administration scale is reported as 0.90 and 0.94 for 
the diet scale.  This study resulted in Cronbach’s alpha 0.70 pre and 0.86 post for the insulin 
administration scale and 0.93 pre and 0.92 post for the diet scale.   
3.5.3  Data Analysis  
Descriptive and inferential analyses were performed using the IBM SPSS Statistics v. 22 (IBM., 
2013).  Missing data accounted for less than 5% of the study data acquired therefore imputation 
was not undertaken (Tabachnick & Fidell, 2001).  Bootstrapping for the regression mediation 
analysis was performed using the PROCESS Macro developed by Hayes (2013). 
Paired-samples t-tests were performed to evaluate the impact of BPG education on participants’ 
scores with the variables perceived stress, ways of coping, and insulin self-efficacy from pretest 
to posttest.  Correlation analyses were run between perceived stress and insulin initiation self-
efficacy, perceived stress and coping, and coping and insulin initiation self-efficacy to examine 
the theoretical relationships hypothesized in the study model. 
Mediated regression analysis was undertaken using a bootstrapping analysis to examine the 
relationship between perceived stress and insulin initiation self-efficacy with coping as a 
mediator.  Bootstrapping is a more recent approach to testing mediation hypotheses which has 
been shown to be superior to earlier methods with regard to power and Type 1 error rates 
(MacKinnon, Lockwood, & Williams, 2004; Preacher & Hayes, 2008).3.6  Results 
3.6.1  Research Question #1  
What is the relationship between perceived stress and education guided by the RNAO BPG for 
Subcutaneous Administration of Insulin in Adult Patients with Type 2 Diabetes? 
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There were statistically significant differences at the p < .001 significance level, in pretest to 
posttest scores for perceived stress and CAI-MDS (insulin self-efficacy) (Table 4).  Results 
showed that patient stress decreased and insulin self-efficacy increased after receiving the BPG 
insulin education.    
Table 4 
Descriptive Statistics and t-test Results for Perceived Stress, Coping, and CAI-MDS (self-
efficacy) 
                                      Pretest               Posttest                     95%Cl for Mean                                                                 
Outcome                      M         SD         M          SD        n          Difference               r           t          df 
Perceived Stress         16.61     7.27        14.23    7.02      97           1.07,  3.71            .58*     3.60*     96 
Coping                        76.38     31.07      73.51    31.22    97        -2.00,  7.756            .70       1.17      96 
CAI-MDS                   76.71     14.23      86.93    10.85    98         -12.90, -7.52          .45*     -7.54*    97 
(self-efficacy) 
*p < .001 
3.6.2  Research Question #2 
What is the relationship between perceived stress, ways of coping and the initiation of insulin 
therapy in adults with type 2 diabetes?   
The correlation analyses indicated perceived stress had a moderately positive correlation with 
coping and a weak, inverse correlation with insulin initiation self-efficacy.   There was a non-
significant relationship between coping and insulin initiation self-efficacy (See Table 5). 
 
Table 5 
Bivariate Correlations Among Perceived Stress, Coping, and CAI-MDS (self-efficacy) 
Variable        1        2         3 
1 Perceived Stress -       .39**      -.21* 
2 Coping          -       .10 
3 CAI-MDS (self-efficacy)                      - 
*p < .05       ** p < .01 
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The paired t-test scores of pretest and posttest for coping suggested fewer coping processes were 
employed posttest, however, this result was not statistically significant (Table 4). 
 
Table 6 presents the bivariate correlations between perceived stress, the 8 subscales of coping 
and the 2 subscales of the CAI-MDS (insulin initiation self-efficacy).  The 8 coping subscales 
include (a) Confrontive Coping, (b) Distancing, (c) Self-Controlling, (d) Seeking Social Support, 
(e) Accepting Responsibility, (f) Escape-Avoidance, (g) Planful Problem Solving, and (h) 
Positive Reappraisal.  The 2 subscales of the CAI-MDS are (a) insulin self-efficacy and (b) diet 
self-efficacy. 
Table 6  
Posttest Bivariate Correlations Among Perceived Stress, Coping (subscales), and CAI-MDS 
(insulin initiation self-efficacy subscales) 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1  Perceived    
    Stress 
- .22* .25* .34* .17 .37* .44* .16 .09 -.17 -.19 
2  Confrontive  
    Coping 
 - .34* .60* .46* .46* .35* .54* .33* -.01 .03 
3  Distancing 
 
  - .55* .37* .59* .38* .37* .40* .13 .05 
4  Self- 
    Controlling 
   - .40* .61* .47* .57* .41* .10 -.01 
5  Seeking  
    Social Support 
    - .31* .26* .50* .47* .07 .17 
6  Accepting 
    Responsibility 
     - .53* .39* .44* .03 -.01 
7  Escape- 
    Avoidance 
      - .03 .19* -.11 -.17 
8  Planful  
    Problem 
Solving 
       - .49* .22 .22* 
9  Positive  
    Reappraisal 
        - .01 .08 
10  Insulin  
      Self-Efficacy 
         - .55* 
11  Diet  
      Self-Efficacy 
          - 
*p = < .05 
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The mediated regression analysis examined the relationship between perceived stress and CAI-
MDS (insulin initiation self-efficacy) with coping as a mediator.  Regression analyses 
demonstrated statistically significant relationships between perceived stress and insulin initiation 
self-efficacy (β = -0.208, p < .05), perceived stress and coping (β = 0.390, p = < .001) and 
perceived stress and coping predicting insulin initiation self-efficacy (see Figure 4).  A bias-
corrected bootstrap 95% estimate of the confidence interval for the indirect effect of coping 
(.153) based on 5000 bootstrap samples was entirely above zero (0.023 to 0.281).  Since the 
confidence interval did not include zero, the indirect effect of coping was shown to be a mediator 
of the relationship between perceived stress and insulin initiation self-efficacy.   
 
3.6.3  Hypotheses Results 
(1) Effective provision of the RNAO BPG for the Subcutaneous Administration of Insulin in 
Adults with Type 2 Diabetes will assist with decreasing patients’ perceived stress. 
Pretest to posttest scores for perceived stress demonstrated a statistically significant decrease 
therefore this hypothesis was supported. 
(2) Patients with higher levels of perceived stress will have lower confidence in 
administering insulin and managing diet (insulin initiation self-efficacy). 
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The study findings of an inverse, although weak correlation between perceived stress and CAI-
MDS (insulin self-efficacy) supported this hypothesis.   
(3) Patients with higher perceived stress will engage more frequently in ways of coping. 
There was a moderately positive correlation between perceived stress and coping which 
supported this hypothesis. 
(4) Patients with effective ways of coping will have higher confidence in administering 
insulin and managing diet (insulin initiation self-efficacy). 
The correlation between coping and insulin self-efficacy was non-significant therefore this 
hypothesis was not supported. 
(5) Coping (ways of coping) is a mediating variable of the perceived stress and initiation of 
insulin relationship. 
The results of the mediated regression analysis supported this hypothesis. 
3.7  Discussion  
The first study aim was to examine the relationship between perceived stress and the influence of 
education guided by the RNAO BPG for the administration of insulin in adults with type 2 
diabetes.  The findings supported the hypothesis that there would be a significant decrease in 
participants’ stress scores following their two appointments for insulin initiation education at the 
diabetes education centre (DEC).  Perceived stress was inversely related to a participant’s insulin 
initiation self-efficacy i.e. as stress decreased the participant’s insulin self-efficacy increased.  
The improvement in insulin initiation self-efficacy scores was also significant.  Researchers have 
suggested that determining a patient’s overall general stress response, as done in this study, may 
be more beneficial in determining strategies to assist with self-management versus focusing on 
diabetes distress (Albright, et al., 2001).  These findings highlight the need to assess patients 
individually to determine how stress may impact their learning ability and affect their ability to 
acquire the skills needed to self-administer insulin effectively.   
The second aim of this study was to examine the relationships between perceived stress, ways of 
coping, and insulin initiation self-efficacy and determine whether coping mediated the 
relationship between perceived stress and insulin initiation self-efficacy.  Findings supported that 
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perceived stress and coping were significant predictors of insulin initiation self-efficacy which is 
consistent with the Lazarus and Folkman theoretical framework in this study.  Coping was 
shown to be a mediator of the relationship between stress and insulin initiation self-efficacy. This 
is consistent with the findings of Lazarus and Folkman who have emphasized that coping 
mediates any emotions that may be generated during the emotions process (2006).   Research in 
diabetes care has suggested that with training, effective coping skills can be developed and 
enhanced (Rubin & Peyrot, 1999).  Hart and Grindel suggested that coping uniquely accounted 
for a  9% significant variance in self-care behaviour with higher self-care behaviour resulting in 
better controlled diabetes (2010).  This is an important element of diabetes self-management 
education as patients need to build a strong foundation of knowledge and skills to carry them 
over the lifetime of their chronic disease management.   Diabetes nurse educators and allied 
health providers are well positioned to assist patients in the development of coping processes that 
will result in improved self-care behaviour. 
3.7.1  Practical Implications 
Research supports the use of a team approach which includes nurse and dietitian diabetes 
educators.  Not all patients will have access to a diabetes education centre as was the situation in 
this study.  With the majority of diabetes management occurring in primary care settings, the 
integration of a diabetes educator into the primary care team could help to improve patients’ 
ability to self-manage.  The results of this study suggest assessment of stress and coping would 
be beneficial for patients initiating insulin therapy.  An awareness of the patient’s stress level and 
coping processes can help tailor the education provided to meet the individual’s needs.  The use 
of a short stress survey such as the Perceived Stress Scale can easily and quickly be administered 
prior to an appointment or education session and can provide useful insight into the patient’s 
stress level.  It can also serve to encourage patient self-reflection and dialogue between the 
patient and educator which allows for exploration of patient questions or concerns.  The RNAO 
BPG is an evidence-based guideline that can be applied by healthcare providers with or without 
speciality knowledge in diabetes.   The findings suggest that the use of a best practice guideline 
can help patients to become self-efficacious with insulin therapy and also help to decrease their 
stress levels.   
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 3.7.2  Limitations 
Convenience sampling limits the generalizability of this study.   The use of a control group that 
did not receive BPG education would have provided a more robust design.  The standard of care 
for diabetes education centres, however, is to provide at least one appointment providing basic 
education with regard to insulin injection, home glucose monitoring, and potential safety 
concerns such as hypoglycemia.  All of the questionnaires used were self-report which may have 
influenced participant responses.  Patients with diabetes often report self-blame (Karlsen, et al., 
2012).  If participants struggled with their diabetes self-management, they may have felt the need 
to provide desirable survey responses.     
3.8  Conclusion 
The incidence of type 2 diabetes continues to increase exponentially throughout the world 
(International Diabetes Federation, 2013) and there is strong research evidence for the benefits of 
glycemic control to minimize the complications of diabetes and improve quality of life (United 
Kingdom Prospective Diabetes Strategy (UKPDS) Group, 1998).  Clinical practice continues to 
evolve with a move to reduce clinical inertia amongst health care providers regarding the use of 
insulin therapy.  Increasing numbers of patients with diabetes will require insulin therapy to 
achieve target glycemic control. The holistic approach of nursing lends itself to meeting both the 
psychological (stress and coping) and physiological (insulin initiation self-efficacy) needs of 
patients living with diabetes.  This study provided evidence that the needs of these patients can 
be met with structured education through the use of a Best Practice Guideline.  Strategies to 
decrease patient stress and improve coping may help to improve patient self-efficacy with insulin 
therapy.    
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Chapter 4 
4 Evaluating the Use of a Best Practice Guideline with Insulin 
Initiation in Type 2 Diabetes 
4.1 Introduction 
Providing patient-focused quality care is one of the quintessential tenets of the nursing 
profession.   Nursing practice continues to advance as our knowledge of health and health care 
provision incorporates new research and enhanced understandings of the needs of those we care 
for.  The movement to evidence-based care gained momentum in the 1990s as clinicians 
articulated the need for the integration of clinician expertise in combination with systematic 
clinical research evidence (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996).  Best 
practice guidelines (BPGs) are now used in clinical practice to provide healthcare professionals 
with a synthesis of the research and expert knowledge related to a specific issue or concept.   
Nelson (2014) examined the concept of best practice in nursing and its increasing presence in the 
literature noting that the evaluation of best practice guidelines is an area that requires further 
development.   Evaluating best practice guidelines allows healthcare providers to determine the 
feasibility of implementing the BPG, its potential to influence patient satisfaction, and whether it 
is cost-effective (Mezey, Fulmer, Abraham, & Zwicker, 2003).  In this paper the results are 
presented of research examining the use of a BPG evaluation tool (Appendix B) with education 
guided by the RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 
Diabetes (Registered Nurses Association of Ontario, 2009). 
4.2 Background 
The use of evidence-based clinical practice guidelines provides clinicians with tools and 
resources to assist patients to optimize their health.  In 1999, the Registered Nurses Association 
of Ontario (RNAO) in collaboration with the Ontario Ministry of Health and Long Term Care 
began a Best Practice Guideline (BPG) development program.  To date over 50 BPGs have been 
developed encompassing a wide variety of clinical subject areas such as diabetes, pain 
management, and facilitating client-centred learning (Registered Nurses Association of Ontario, 
2015).  The development of an RNAO BPG is a rigorous process which includes topic selection 
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by key stakeholders, critical appraisal of the literature by an expert panel, data extraction and 
draft of BPG recommendations, review of the draft by external stakeholders with subsequent 
revision of the BPG, and finalization of the BPG and related educational, implementation, and 
evaluation tools (Virani & Grinspun, 2007).  Guidelines are to be reviewed and updated every 3 
years or more frequently as necessary.  (However, the BPG involved with this study has not been 
revised since 2009).  The final versions of the RNAO BPGs provide recommendations in 4 main 
areas:  clinical practice, aimed at nursing; educational, directed at practice competencies; 
organizational/policy, directed at the organizational environment to facilitate practice and 
evaluation/monitoring indicators of the BPG (Registered Nurses Association of Ontario, 2009).    
Clinical recommendations can be used by nurses and collaboratively with allied health providers 
to enhance direct patient care.      
Numerous organizations such as the AGREE Collaboration, Guidelines International Network, 
and  RNAO champion the evaluation of clinical practice / best practice guidelines (Makarski & 
Brouwers, 2014; Network., 2002; Registered Nurses Association of Ontario, 2015).  The 
AGREE collaboration, a group of international guideline developers and researchers, developed 
the AGREE II instrument, to provide a framework to assess clinical practice guideline (CPG) 
quality (Brouwers et al., 2010).  The authors noted that CPGs are relied upon by clinicians to 
make patient care decisions and can also play an important role in health policy formation and 
thus must be of high quality to ensure best possible patient care.  Uptake of the AGREE 
instruments has been extensive with translation of the instruments into 33 languages and over 
600 article citations which emphasizes the value ascribed to guideline evaluation.  Nurse 
researchers also recognize the critical role guideline evaluation plays and encourage healthcare 
professionals to carefully consider guideline evaluation in addition to guideline adoption 
(Graham & Harrison, 2005) .  
Type 2 diabetes affects 90% of those people living with diabetes (Centre for Disease Control and 
Prevention, 2014; Government of Canada, 2013).    The challenge for people living with diabetes 
is to achieve glycemic targets that will help to decrease the probability of developing the 
devastating complications of the disease.  People living with diabetes have a mortality rate of at 
least twice as high as those without diabetes (Public Health Agency of Canada, 2011a).  
Macrovascular complications such as heart attack and stroke and microvascular complications 
such as retinopathy, nephropathy, and neuropathy can be minimized or avoided with optimal 
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blood sugar control (Brownrigg et al., 2014; Holman, et al., 2008; Reyden et al., 2013; United 
Kingdom Prospective Diabetes Strategy (UKPDS) Group, 1998) . Many people, however, have 
difficulty achieving the recommended glycemic targets.  Only 50% of Canadians living with 
diabetes are reported to have achieved the recommended glycemic targets (Leiter, et al., 2013a).   
The reasons for this are multifactorial and include psychological aspects, socioeconomic 
influences, access to care and education, and the progressive nature of diabetes (Canadian 
Diabetes Association, 2013a).   
A challenge for professionals providing diabetes care is to provide patient-focused education 
within the constraints of a healthcare system that often limits the time available to interact with 
patients.  The psychological aspects of diabetes are well documented and include the phenomena 
of diabetes distress and psychological insulin resistance.  Diabetes distress, disease specific stress 
related to the burden self-care management of diabetes is established in the literature, as well as 
the challenges associated with its identification and treatment (Fisher, et al., 2009; Paddison, et 
al., 2007; Peyrot, et al., 2005; Peyrot, et al., 2006).  Psychological insulin resistance is defined as 
a psychological barrier or opposition to initiation of insulin (Brod, et al., 2009; Gherman, et al., 
2011; Polonsky, 2007)  and is present in both clinicians and patients. A related concept, clinical 
inertia is the term used to describe reluctance by healthcare providers to initiate new treatments 
such as insulin therapy (Brown, et al., 2004; Harris, et al., 2010b; Harris, et al., 2008; Phillips, et 
al., 2001). Reluctance to initiate insulin often results in prolongation of hyperglycemia which 
unnecessarily increases the risk of diabetes complications and mortality.   Additionally, 95% of 
diabetes care is self-managed emphasizing the importance of effective, efficient educational 
interactions (Funnell & Anderson, 2000).  The RNAO BPG for the Subcutaneous Administration 
of Insulin in Adults with Type 2 Diabetes provides an evidence-based, structured resource for 
nurses caring for patients needing to initiate insulin therapy. This study examines participants’ 
recall of the content of the RNAO BPG for the Subcutaneous Administration of Insulin in Adults 
with Type 2 Diabetes using a BPG evaluation tool developed for this study.  This study was 
derived from a quantitative study examining stress, ways of coping, and insulin initiation self-
efficacy (Loft, Forchuk, Kerr, & Harris, 2015). 
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4.3 Research Purpose 
The purpose of this research was to examine participant recall of diabetes education based on the 
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
when initiating insulin therapy and to examine a BPG evaluation tool developed for this study 
for use specifically with this RNAO BPG.  
The research questions were: 
1.  “What is the level of participant recall of diabetes education using the RNAO BPG for the 
Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes as evaluated by a novel 
BPG evaluation tool?”  
2.  “What is the patient experience of initiating insulin therapy when receiving structured Best 
Practice Guideline diabetes education?” 
The terms recall and retention have similar meanings, however, for this study the term recall was 
chosen. The term “participant recall” describes more closely the elements of the BPG education 
that participants remembered.  The challenge with using the term retention was the implication 
that all of the elements of the BPG had been presented by the educators to the participants which 
might not have occurred.   
4.4 Methods 
4.4.1  Design and Sample  
A pretest / posttest, non-experimental, mixed-methods design utilized one group of participants.  
A convenience sample was drawn from patients attending one of three independent Diabetes 
Education Centres in Southwestern Ontario for the initiation of insulin therapy.  Participants 
were adults over the age of 18 with no prior history of injection or insulin therapy.  Ethics 
approval was obtained from the Western University Health Science Research Ethics Board.    
Participants were interviewed following two appointments to receive insulin therapy education 
with the first appointment providing the education to initiate insulin therapy.  The second 
appointment was a follow-up approximately six weeks after the initiation of insulin.  During one 
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to one education sessions, diabetes educators (registered nurses or registered dietitians) provided 
education which focused on the clinical recommendations of the RNAO BPG.  Education 
sessions ranged from 45 to 90 minutes.  Participants were interviewed by a member of the 
research team in person or by telephone following their six week appointment to complete the 
RNAO BPG evaluation tool.  Three open ended questions were also included during the 
interview:   1. “Please describe how you felt when you were asked to start using insulin”, 2. 
“What was the most challenging thing about starting insulin?”, 3.”What made it easier to start 
using insulin?”. Ethics approval was obtained from the Western University Health Science 
Research Ethics Board and for each Diabetes Education Centre involved in the research.     
4.4.2  Instruments 
A  Best Practice Guideline evaluation tool was developed for this study to be used with the 
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
(Registered Nurses Association of Ontario, 2009).  Designed to be used during a face to face or 
telephone interview, it was developed to be consistent with chart audit tools previously 
developed by the Nursing Best Practice Research Unit (NBPRU) (Edwards et al., 2003).  Prior to 
use in this study, the tool was reviewed and revised by clinical experts working in diabetes.  
Experts familiar with RNAO BPG development and implementation also reviewed the novel 
evaluation tool.  No changes were recommended by the clinical or BPG experts with respect to 
the content of the evaluation tool.  Revisions were made to ensure clarity of the questions and to 
ensure each question evaluated a single concept.  The tool evaluates participant recall of clinical 
practice recommendations from the RNAO BPG for the Subcutaneous Administration of Insulin 
Adults with Type 2 Diabetes, for example, “Did the educator assess stressors about insulin 
initiation with the patient?  Was the patient asked to set a goal for the education session?”.  There 
are 22 items with a yes or no response with yes = 1 point, no = 0 points.  Scores can range from 0 
to 22.  Higher scores reflect higher recall of this study’s RNAO BPG content by the participant.  
4.4.3  Analysis 
Descriptive statistics and the reliability score of the BPG evaluation tool were obtained using the 
IBM SPSS Statistics v. 22 (IBM., 2013).  The level of participant recall of the content of the 
BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes was 
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evaluated by determining participants’ total score obtained with the evaluation tool developed for 
this study. 
Qualitative data from the open-ended questions included on the BPG evaluation tool were 
transcribed verbatim during the interview.  Using the approach described by Hsieh and Shannon 
(2005) a conventional content analysis approach was undertaken.  Content analysis offers a 
flexible approach to extend knowledge of the human health experience.  Participant responses 
were analyzed and coded to enable a deductive analysis and determine categories of participant 
responses.  Exemplars from each category were selected to provide further insight into 
participant experience with insulin initiation and BPG education.    
4.5 Results 
A final sample size of  n = 105 was obtained from participants who completed the two DEC 
appointments and the BPG evaluation interview. (Table 1) 
Demographics 
Table 1: Demographics of final sample (n = 105) (Loft, et al., 2015) 
Demographic Frequency % 
Sex 
     Female 
     Male 
Marital Status 
     Single 
     Married  
     Divorced/Separated 
     Widowed 
Education 
     Elementary School 
     High School 
 
47 
58 
 
6 
71 
21 
7 
 
11 
44 
 
45 
55 
 
6 
68 
20 
7 
 
11 
42 
59 
 
 
 
 
 
4.5.1  BPG Evaluation Tool  
The Cronbach’s alpha an estimate of the internal consistency for the BPG evaluation tool was 
calculated to be 0.57.  Removing the first item of the tool, “Did the educator ask you about your 
beliefs about insulin therapy?” increased the Cronbach’s alpha to 0.70 which is considered an 
acceptable internal consistency.  Final analysis was therefore done with the first item removed 
from the original BPG evaluation tool leaving a total of 21 items in the final scale. 
The mean score on the Best Practice Evaluation tool to assess participant recall of the BPG 
content was 16.7 (SD = 2.19) resulting from a possible maximum score of 21.    The frequency 
scores of patient recollection of the BPG content reviewed during their appointments are 
summarized in Table 6.   
Table 6  
Best Practice Guideline response frequency 
BPG Question Summary 
(N = 105) 
Frequency  
(yes) 
% 
(yes) 
Did your educator ……   
     ask you to set a goal for your education session? 
     provide basic nutrition information? 
 
27 
105                  
26 
100 
     College 
     University 
Insulin Regimen 
     Basal (Once daily) 
     Multiple Daily Injections 
30 
19 
 
84 
21 
28 
18 
 
80 
20 
 range          mean          SD 
Age (yrs) 
Duration with Diabetes (yrs) 
25-86            62          10.73 
  0-36          11.6          7.74 
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Insulin preparation and administration 
     review your type of insulin?  103 98 
     review the action of your insulin? 101 96 
     review the stability of your insulin? 
     review the storage of your insulin? 
     review the compatibility of your insulin? 
     review injection technique? 
     review sharps disposal? 
Self-monitoring of blood glucose (SMBG) 
     review the frequency of blood glucose testing? 
     review the recommended targets for blood glucose?    
     review how to verify meter accuracy? 
     review SMBG technique? 
Hypoglycemia education 
     review how to prevent hypoglycemia? 
     review how to recognize hypoglycemia? 
     review how to treat hypoglycemia? 
     ask if family members were aware of hypoglycemia treatment? 
Sick Day Management 
     review blood glucose monitoring during periods of illness? 
     ask you when you should seek healthcare assistance? 
     review use of easily digested carbohydrates? 
     review how to prevent dehydration? 
101 
102 
99 
100 
100 
 
104 
104 
83 
104 
 
101 
102 
102 
94 
 
57 
62 
30 
27 
 
 
96 
97 
94 
100 
100 
 
99 
100 
79 
99 
 
96 
97 
97 
90 
 
54 
59 
29 
26 
   
 
The majority of BPG items were recalled by greater than 90% of the participants.  Items related 
to sick day management, meter accuracy, and patient goal setting were recalled at noticeably 
lower rates (26-59%). 
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4.5.2  Participant Interviews 
Participants’ responses to the open ended questions asked following their second appointment 
were analyzed.  Three distinct categories emerged:   1. Psychological Insulin Resistance,  2. 
Insulin Therapy Preconceptions, and 3. Educational Impact.  Interview lengths ranged between 6 
and 16 minutes which included the completion of the BPG Evaluation Tool.  In total, 98 
participants provided responses to the open-ended questions with 7 participants preferring not to 
respond. 
4.5.3  Psychological Insulin Resistance (PIR) 
The majority of patients described some element of PIR - the psychological barrier or opposition 
to initiation of insulin (Brod, et al., 2009; Gherman, et al., 2011; Polonsky, et al., 2011).  
Participant responses were consistent with previous research which identified emotional 
elements such as anxiety, depression, fear of needles or injection pain, and the belief that 
diabetes is worsening as barriers to insulin initiation (Gherman, et al., 2011).  
Describing his reaction to the need to initiate insulin therapy, a 72 year old male who had been 
living with diabetes for 14 years responded, 
“Another step down into the basement. I felt like it was the end of the road. I'm gonna be dead. 
Sticking a needle into me was the worst fear. But now I realize that I should have gone on insulin 
years ago. I just didn't think I could do the needle.” 
Similarly, a 49 year old male with a 2 year history of diabetes commented,  
“I saw it as a "no turning back" kind of thing. Insulin seemed like a death nail, it's for life. This 
stuff messes with your head. It's like you're going down a path of unhealthiness. Now, injecting 
the insulin is not a big deal.” 
4.5.4  Insulin Therapy Preconceptions  
Many patients appeared to have a lack of knowledge related to the current methodologies for 
insulin therapy.  Their understanding of insulin therapy was often based on the experience of 
others who had started insulin therapy prior to the newer modalities now available.  
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Misconceptions regarding insulin therapy have been identified in the literature with some 
patients attributing such things as heart attack, amputation, and blindness as resulting from the 
use of insulin (Karter et al., 2010). 
“It wasn't good. I didn't know about all the new needles. My sister had diabetes and she had long 
needles and she had to boil them. It was so much work.” (62 year old female with 1 month 
history of diabetes) 
“I was very nervous and unsure about it. The impact is pretty good that it (insulin) is working. I 
wondered about the needle and how painful it would be.  It's kind of mind over matter. It's not 
anywhere near as bad as when my father was a diabetic - that was why I thought it was so 
terrible. He had to boil his needles and everything. But once you see that it's just a pen, it's really 
quite easy.” (66 year old male with 14 year history of diabetes). 
4.5.5  Educational Impact 
The impact of RNAO BPG education could be seen in comments that expressed a negative 
response to the need to begin insulin therapy but suggested a positive opinion of the education 
that was received. 
“No way! I hated needles. I've gotten enough control over it now. I realize that I have to be on 
the insulin. I've been avoiding it for years. I just hated the thoughts of being diabetic and being 
on insulin made it real that I was a diabetic.  The education has helped. I know it's ok to be 
diabetic.” (56 year old male with 5 year history of diabetes) 
“I didn't really want to. At first he kept saying lose some weight but I just couldn't. It came down 
to the point where he said ‘You better be on insulin’ now I know it's so easy. The needles are so 
small and they don't even hurt. The needles. I just didn't like the word - needles. The educators 
were very knowledgeable. That's very good.”(70 year old female with 14 year history of 
diabetes) 
No negative comments regarding the BPG education were expressed by participants in this 
study.  Comments by participants did not identify any specific educational elements of the BPG 
referring to the education as a more global experience.  Participants appeared to value their 
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interaction with the diabetes healthcare providers, and often contrasted current knowledge with 
past preconceptions.    
“I was diagnosed 28 years ago. My doctor took me aside and said that I would one day need 
insulin. I was terrified though. I didn't sleep at all before coming in (for this appointment). I feel 
a lot more secure. The educators 28 years ago put the fear of God in you. You're going to be 
dead. This time it was all about them listening to me. I felt like I was heard.” (58 year old male 
with 28 year history diabetes) 
“Support from the diabetes education doctors and nurses. They have a very good education 
program.”(44 year old male with 6 year history of diabetes) 
4.6  Discussion 
There was effective provision of the RNAO BPG with the average score ( 16.71 out of 21 ) from 
the evaluation tool indicating that 80% of the RNAO BPG content was recalled by participants 
as having been discussed during their appointments. Previous evaluations of RNAO BPG have 
included the evaluation levels recommended by Kirkpatrick and Kirkpatrick (2007).  Level 1- 
Reaction, relates to the degree of participant satisfaction with the education, Level 2 – Learning,  
relates to the degree to which participants gain the intended knowledge, skills, attitudes and 
confidence, Level 3- Behavior – relates to the degree to which participants and staff apply what 
has been learned and Level 4 – Results- relates to targeted patient outcomes. This study provided 
Level 2 results reporting patient knowledge gained through the use of the RNAO BPG.  In the 
related intervention study by Loft et al. (2015) which examined stress and insulin initiation self-
efficacy prior to and following the RNAO BPG guided education, there was a statistically 
significant decrease in participants’ stress scores.  Additionally, there was a statistically 
significant increase in participants’ insulin therapy self-efficacy scores.  Both the BPG 
evaluation tool findings and participant interview responses support the positive impact of the 
RNAO BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes. 
The BPG evaluation tool results revealed, however, that items associated with sick day 
management were not recalled as consistently as other elements of the BPG.  Study design did 
not allow for identification of the cause of this deficit (i.e. not communicated effectively by 
educators or reduced uptake by participants).  This is an important area for further research.  
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Although sick day management may not occur frequently, it is essential for a patient to have the 
recall knowledge to manage sick day issues when they arise.  If patients are unable to self-adjust 
insulin dosing or prevent dehydration, medical intervention may be required leading to 
utilization of their primary care provider or potentially urgent emergency room access.  
Participant inclusion in goal setting for the education sessions also demonstrated low recall with 
only 26% of the participants recalling the opportunity to set a goal for their insulin initiation 
education.  In order to truly provide patient-centred care it is important to fully engage the 
patient in shared decision-making.  Patient-directed goal setting reflects one of the essential 
elements of motivational interviewing (MI) which is a concept that has become one of the 
preferred approaches in chronic disease management  and is particularly relevant in diabetes 
(Kalra, Kalra, & Batra, 2010; Levich, 2011).  Motivational interviewing, as defined by Rollnick 
and Miller (1995), is  a directive, client-centred counseling style aimed at promoting behavior 
change in clients as they resolve their ambivalence.  Motivational interviewing in Type 2 
diabetes has been shown to be a more effective approach for improving patient self-management 
(Li, Li, Shi, & Gao, 2014), to improve depressive symptoms and time spent exercising in 
American Indians (Calhoun et al., 2010), and was preferred over standard care in a qualitative 
study with focus groups in family practice clinics (Dellasega, Tiangco, & Gabbay, 2012).  This 
finding from the BPG evaluation tool highlights a key area for improvement in patient-centred 
diabetes education, reminding nurses and interprofessional team members to fully engage their 
patients to increase patient engagement and success.   
This was the first use of this newly developed  BPG evaluation tool for this RNAO Best Practice 
Guideline.   Three items of the tool showed no variance and could be deleted. These related to 
whether insulin injection, disposal of needles or syringes, and basic nutrition information were 
reviewed during the education sessions. Further revision and evaluation of the tool would be 
beneficial for future research and to compare diverse BPGs.  
The participant interview qualitative responses were consistent with the current literature with 
respect to psychological insulin resistance.  Preconceptions and misconceptions regarding insulin 
are also common in the literature, particularly in patients who are reluctant or refuse to initiate 
insulin therapy (Polinski et al., 2013).   Although PIR is well recognized the challenge has been 
to find a mechanism to readily identify it and then work to minimize it.  It is difficult to 
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generalize strategies to decrease PIR as strategies need to be tailored to the unique needs of the 
patient.  The participant responses in this study support the findings of Polonski et al. (2013) who 
suggested that once patients become familiar with insulin therapy it becomes much less of a 
barrier.   
4.7  Limitations 
The Canadian Diabetes Association clinical practice guidelines and the RNAO BPG endorse the 
need for patient education with the initiation of insulin.  Given these recommendations, the study 
design did not include a control group that did not receive insulin initiation education.  A control 
group would have offered a more robust design for this research.   Convenience sampling 
increases the likelihood of participant bias and decreases the generalizability of these findings.  
Study design did not include an instrument to assess the provision of the BPG by the diabetes 
educators.   The BPG evaluation interview was not an in-depth interview which limited the depth 
of the qualitative analysis possible.  Participant responses to the open-ended questions on the 
BPG evaluation tool were manually transcribed during the interviews which limited the quantity 
of data that could be collected.  The primary researcher was directly involved with the majority 
of data collection.  The BPG itself has not been revised since 2009 which introduces the risk that 
clinical best practices have likely evolved since the BPG introduction. 
4.8  Conclusion 
The BPG evaluation tool developed for use with the RNAO BPG for the Subcutaneous use of 
Insulin in Adults with Type 2 Diabetes was effective in this study and requires only a short time 
to administer.  Participants’ preconceived ideas or previous exposure to insulin therapy, through 
that of a friend or relative, identified a knowledge deficit related to the current insulin therapy 
modalities available today. The participant interview responses reinforce the need for early 
patient education regarding the pharmacologic agents, including insulin, used to manage 
diabetes.   Ideally, education should begin at the time of a patient’s diabetes diagnosis with 
insulin being presented as just one of the options available and not used as a threat or in a treat to 
failure approach.  Patients need to have a clear understanding of the relative ease with which 
insulin therapy can be incorporated into an active, healthy lifestyle.  Nurses, in collaboration 
with the interprofessional team, need to ensure that patients do not experience unnecessary 
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anxiety or stress related to an obsolete understanding of how insulin therapy is provided today.  
The results from this study provided evidence that the RNAO BPG for the Subcutaneous 
Administration of Insulin in Adults with Type 2 Diabetes can be an effective tool in the 
provision of insulin initiation education. 
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Chapter 5 
5. Discussion 
This final chapter is a summary of the research findings with a discussion of implications and 
recommendations for future research.  The purpose of this dissertation was to examine perceived 
stress and coping in adults with Type 2 diabetes who initiated insulin therapy after receiving an  
education intervention guided by a Best Practice Guideline (BPG).  The research questions were:  
(a) What is the relationship between perceived stress and diabetes education guided by the 
Registered Nurses Association of Ontario (RNAO) BPG for the Subcutaneous Administration of 
Insulin in Adult with Type 2 Diabetes who initiate insulin therapy? (b) What is the relationship 
between perceived stress, ways of coping and the initiation of insulin therapy in adults with Type 
2 diabetes?  (c) What is the level of participant recall of diabetes education using the RNAO 
BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes as evaluated 
by a novel BPG evaluation tool? and (d) What is the patient experience of initiating insulin 
therapy when receiving structured Best Practice Guideline diabetes education?”  It was 
hypothesized that effective provision of the RNAO BPG would reduce patient stress and that 
patients with higher levels of stress would have lower confidence with insulin therapy self-
efficacy.  Related to coping, it was hypothesized that patients with higher stress levels would 
enact ineffective coping and that patients with effective coping would have higher confidence 
with insulin therapy self-efficacy.  Finally, coping was hypothesized to be a mediating variable 
in the relationship between stress and insulin therapy self-efficacy. 
5.1 Key Findings 
5.1.1  Stress  
The findings demonstrated a statistically and clinically significant decrease in patient stress after 
receiving the RNAO BPG education.   There was a moderate, positive correlation between stress 
and coping indicating that as stress increased patients needed to enact additional coping 
processes.  There was an inverse correlation between stress and insulin therapy self-efficacy, 
indicating stress decreased as participants became more self-efficacious with their insulin 
therapy, however, the correlation was weak ( r = -.21 ). 
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5.1.2  Coping   
Although coping scores decreased from pretest to posttest, which would reflect a decreased need 
to enact coping processes, the decrease was not statistically significant. As well, the correlation 
between coping and insulin therapy self-efficacy was non-significant.  Coping is a 
multidimensional construct with Lazarus and Folkman identifying eight different types of coping 
processes (Lazarus & Folkman, 1984). The coping processes are categorized as either problem-
focused or emotion-focused coping.  It is important to note that Lazarus stresses that neither type 
of coping process is inherently better than the other and that the environmental context will 
influence the coping processes used (Lazarus, 2006).  Problem-focused processes include 
positive reappraisal, planful problem solving, accepting responsibility, and seeking social 
support.  Emotion-focused coping strategies include distancing, self-controlling, confrontive- 
coping, and escape-avoidance (Lazarus & Folkman, 1984).  The complexity and 
multidimensionality of coping may have made it difficult to demonstrate a difference between 
pretest and posttest scores.  
Of interest, however, is the finding that coping did mediate the relationship between stress and 
insulin therapy self-efficacy.  How an individual chooses to cope in a given situation is fluid and 
changes with a person’s appraisal of the situation and the environmental context.  Lindley and 
Noble-Walker (1993) noted that a mediator variable often represents a process that is intrinsic to 
an individual .  Lazarus and Folkman suggested that coping is a mediator and emphasized that 
coping mediates any emotions that are generated by the emotions process (Folkman & Lazarus, 
1988; Lazarus, 2006).  The addition of an instrument to further assess a participant’s emotional 
state would have provided data for a more thorough statistical analysis of correlations and 
analysis of variance between the study variables of coping, stress, and self-efficacy.  
5.1.3  Best Practice Guidelines   
The BPG evaluation tool indicated the participants recalled the majority of the RNAO BPG 
content that was presented to them.  Asked to describe their feelings when initiating insulin 
therapy, the majority of participant responses reflected the findings in the literature seen with 
psychological insulin resistance such as fear, reluctance, disappointment and self-blame (Krall et 
al., 2015; Peyrot, et al., 2005).  It was encouraging that after receiving the RNAO BPG education 
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that participant responses indicated satisfaction with the education process and that insulin self-
efficacy scores also increased.   
Two areas that were not recalled adequately by participants included BPG content related to sick 
day management and patient-directed goal setting.  Sick day management is an essential element 
of diabetes self-care management.  Although patients may not experience illness with a high 
frequency, having the knowledge to effectively manage insulin dosing, prevent dehydration, and 
knowing how to modify dietary intake could prevent the need to access higher acuity healthcare 
services.  Therefore it is important that patients have a strategy in place to access sick day 
management information when necessary.  Healthcare providers should provide patients with 
resources in the form of printed materials or web-based information to access should they 
become ill.  Patients should also be encouraged to speak with their pharmacist about their 
medications.  Having patients provide a verbal confirmation to the question, “What would you 
do if you were sick and couldn’t take your insulin?” will allow care providers to assess if patients 
have a good understanding of what they need to do should they become ill.   
The low rate of participant recall of being asked to set a goal for their education session is cause 
for concern.  Critical for engaging patients in their diabetes self-management is the need to 
employ counseling approaches, such as motivational interviewing, which encourages patients to 
self-direct their care.  Motivational interviewing has been shown to be a more effective approach 
for improving self-management in patients with Type 2 diabetes than traditional educational 
approaches (Li, et al., 2014).  To ensure patients feel engaged in the education process, putting 
their education goals in writing or perhaps having them verify their goal as it is entered into their 
health record can be of benefit.  For healthcare providers using electronic health records, the use 
of mandatory reporting fields that call for patient-driven goals to be entered can prompt 
providers to ensure goal-setting is reviewed.   
5.2 Implications and Future Research 
The findings of this study provided clear evidence that there is more work that needs to be done 
to improve the patient experience for adults with Type 2 diabetes initiating insulin therapy.  The 
use of a Best Practice Guideline that can assist with structured education has been shown in this 
study to decrease patient stress and improve insulin initiation self-efficacy.  The task now is to 
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integrate the use of a BPG into primary care practice settings where the majority of diabetes 
clinical management occurs. In Canada,  patients with diabetes have 1.42 times as many visits to 
primary care than patients without diabetes (Greiver et al., 2013).  Improvements into the 
provision of insulin initiation education will require changes on several levels.   
At the macro level, funding for primary care must be sufficient to allow family practice settings 
to have access to adequate human resources such as nurses with diabetes expertise.  Adequate 
clinic time must also be available to provide diabetes education, particularly for patients needing 
to initiate insulin.  As the prevalence of diabetes continues to grow, the numbers of patients 
requiring insulin therapy will also continue to grow.  The healthcare system must be able to 
accommodate the needs of patients initiating insulin therapy to ensure that they feel confident to 
effectively manage their insulin therapy which should lead to improved glycemic control and the 
minimization of diabetes complications.   
At the healthcare provider level, psychological insulin resistance (PIR) is well recognized in the 
literature in the form of clinical inertia. Some clinicians do not feel confident that their patient 
will be able to cope emotionally with insulin therapy or be able to acquire the skills necessary to 
safely manage insulin therapy.  Others cite lack of time and resources to teach insulin therapy.  
Despite educational efforts to assist healthcare providers to confidently prescribe and initiate 
insulin, it is evident that some reluctance remains (Krall, et al., 2015).  Unfortunately, the 
paradigm of using patients’ fear of insulin as a leveraging agent to target weight loss and dietary 
compliance also continues to be an issue.  As clinicians become more confident with initiating 
insulin therapy and motivational interviewing becomes a standard approach for patient 
counselling, it is hopeful that using the “threat” of insulin will no longer be an issue.   
It is possible that the elevated stress level that participants experienced prior to initiating insulin 
therapy included some element of self-blame or feelings of failure when insulin became 
necessary to control their diabetes.  It will require continued reinforcement, by providers with 
insulin therapy expertise, to promote the need for insulin therapy education at the outset of a 
patient’s journey with diabetes and that insulin is presented in a positive light. 
At the patient level, the presence of psychological insulin resistance (PIR) has also been well 
researched.  The majority of participants in this study described some element of PIR during the 
short interview component including such emotional elements as anxiety, depression, and fear of 
81 
 
 
 
needles.   Further research is necessary, however, to explore specific strategies and educational 
modalities to decrease PIR concepts such as injection phobia, needle phobia, fear of weight gain, 
hypoglycemia, and lifestyle accommodations (Larkin et al., 2008; Nam, et al., 2011). 
Misconceptions and preconceptions regarding insulin therapy were clearly demonstrated in this 
study.  Many researchers have recommended introducing the concept of insulin therapy at the 
outset or early into a patient’s journey with diabetes.  Reluctance to the early introduction of the 
concept of insulin therapy is found both in clinician and patient populations who would benefit 
from further research to provide evidence of its benefit and promote adoption of early insulin 
education as the norm in diabetes education and practice.   
The ubiquitous nature of diabetes provides a strong case for increasing the awareness of diabetes 
management including insulin therapy to a broader audience than just those living with diabetes.  
As evidenced in this study, patients clearly listen to the narratives of their friends and family.  
Indeed, research has shown that it is the information received from family and friends that is 
often valued more highly than that received from healthcare professionals.  Educating the general 
public about the advances in diabetes management and insulin therapy at health fairs, in print 
media such as popular magazines, electronic media, or social media may help to dispel some of 
the misconceptions present today.   
Future research to extend upon the findings of this study should be done in primary care settings 
such as family health teams or Nurse-Practitioner Led clinics where the majority of diabetes 
management actually occurs versus the specialized environment of the Diabetes Education 
Centres.  This would also allow for further exploration of the impact of the Best Practice 
Guideline when utilized by providers not specialized in diabetes care.  Further study needs to be 
undertaken exploring coping processes in patients on insulin therapy, examining the relationship 
between coping and glycemic control.  Is there a difference in glycemic control between patients 
who enact effective coping processes versus patients who do not?  A qualitative study that 
provides a more in-depth examination of the patient experience of the education process during 
transition to insulin therapy would illuminate our understanding of the patient experience 
identifying possible gaps education or clinical care.  An intervention study that provided 
alternative methods for decreasing stress when initiating insulin therapy such as guided 
meditation, peer to peer support, or use of technology such as smartphone application may help 
to identify which strategies are more effective in reducing diabetes-related stress.   
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5.2.1  Implications for Nursing 
Nurses are ideally positioned to advocate for, educate, and assist patients transitioning to insulin 
therapy.  With a presence in primary care, ambulatory care, acute care, and long term care nurses 
have multiple contact points with patients and their families to dispel misconceptions of insulin 
therapy.  As direct care providers, nurses can advocate for the use of best practice guidelines and 
the use of assessment tools to ensure patients receive patient-focused education.  The use of a 
brief stress screening tool or coping tool can help to tailor the diabetes education patients require 
and ease the transition to insulin therapy.  Nurse researchers should continue to explore 
opportunities to improve the patient experience of transitioning to insulin therapy including the 
influences of stress and coping as patients work to achieve insulin self-management.  
5.3 Conclusions  
Much has changed in the 94 years since the discovery of insulin.  From purified beef and pork 
insulin to human insulin analogs, from long, thick gauged needles to tiny, thin-walled pen tip 
needles, the physical aspects of insulin therapy have advanced to the point where insulin pumps 
can now deliver subcutaneous insulin in a pattern that mimics the normal human pancreas.  It is 
the psychological aspect of insulin therapy, however, that often prevent patients from achieving 
optimal glycemic control.  Stress and coping can be improved with structured Best Practice 
Guideline education as evidenced by the findings of this study.  For adults with Type 2 diabetes, 
initiating insulin therapy can be a stressful experience but as Lazarus (2006) noted, from such an 
experience can come reorganization of life in ways that leave a person more productive, engaged 
and satisfied.  Nurses and healthcare professionals have an important role in helping patients to 
achieve such a result.  
83 
 
 
 
References 
Folkman, S., & Lazarus, R. (1988). Ways of Coping Questionnaire: Mind Garden, Inc. 
 
Greiver, M., Williamson, T., Barber, D., Birtwhistle, R., Aliarzadeh, B., Khan, S., . . . Katz, A. 
(2013). Prevalence and Epidemiology of Diabetes in Canadian Primary Care Practices:  
A Report from the Canadian Primary Care Sentinel. Canadian Journal of Diabetes, 38, 
179-185.  
 
Krall, J., Gabbay, R., Zickmund, S., Hamm, M., Williams, K., & Siminerio, L. M. (2015). 
Current Perspectives on Psychological Insulin Resistance:  Primary Care Provider and 
Patient Views. Diabetes Technology & Therapeutics, 17(4), 268-274.  
 
Larkin, M., Capasso, V., Chen, C., Mahoney, E., Hazard, B., Cagliero, E., & Nathan, D. (2008). 
Measuring Psychological Insulin Resistance:  Barriers to Insulin Use. Diabetes Educator, 
34(3), 511-517.  
 
Lazarus, R. (2006). Emotions and interpersonal relationships: toward a person-centered 
conceptualization of emotions and coping. Journal of Personality 74(1), 9-46.  
 
Lazarus, R., & Folkman, S. (1984). Stress, Appraisal, and Coping. New York: Springer. 
 
Li, M., Li, T., Shi, B. Y., & Gao, C. X. (2014). Impact of motivational interviewing on the 
quality of life and its related factors in type 2 diabetes mellitus patients with poor long-
term glycemic control. International Journal of Nursing Sciences, 1(250-254).  
 
Lindley, P., & Noble Walker, S. (1993). Theoretical and Methodological Differentiation of 
Moderation and Mediation. Nursing Research, 42(5), 276-279.  
 
Nam, S., Chesla, C., Stotts, N., Kroon, L., & Janson, S. (2011). Barriers to diabetes management: 
patients and provider factors. Diabetes Research and Clinical Practice, 93, 1-9.  
 
Peyrot, M., Rubin, R. R., Lauritzen, T., Snoeks, F. J., Matthews, D. R., & Skovlund, S. E. 
(2005). Psychosocial problems and barriers to improved diabetes management: results of 
the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabetic 
Medicine, 22, 1379-1385.  
84 
 
 
 
Appendix A   
 
 
85 
 
 
 
  
 
 
86 
 
 
 
Appendix B 
RNAO Nursing Best Practice Guideline for the 
Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
Interview Evaluation Tool 
 
Education Audit 
 
Client Eligibility Criteria (all eligibility criteria must be met to proceed) 
 Adults over 18 years of age 
 Diagnosis of Type 2 diabetes 
 Patient has received education by a diabetes educator  at an organization that uses RNAO 
BPG for the Subcutaneous Administration of Insulin in Adults with Type 2 Diabetes 
 
Patient Identification: ____________________________________________________________ 
Date Data Collected:  ____________________________________________________________ 
Organization / Site Data Collected from:  ____________________________________________ 
Data Collector’s Initials: _________________________________________________________ 
 
Patient Age:  __________ 
Patient highest level of education:  _________ 
Gender:  ______________ 
Duration of diabetes:  ___________ 
Diabetes regimen:  _________________ 
 
 
 
Please describe how you felt when you were asked to start using insulin. 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
What was the most challenging thing about starting insulin? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
What made it easier to start using insulin? 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________ 
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1. Did your educator ask you about your beliefs about insulin therapy? 
         □ Yes  □ No 
2. Did your educator ask you to set a goal for the education session?  
□ Yes  □ No 
 
3. Did your educator review:  
a. the type(s) of insulin you are taking?    □ Yes  □ No 
b. how the insulin works in your body?    □ Yes  □ No 
c. how long the insulin can be kept at room temperature? □ Yes  □ No 
d. how to store your insulin?     □ Yes  □ No 
e. if your insulin is compatible with other insulins?  □ Yes  □ No 
f. how to inject your insulin?     □ Yes  □ No 
g. how to safely dispose of your needles or syringes?  □ Yes  □ No 
          
4. Did your educator  review these topics related to Self Monitoring of  Blood Glucose 
(SMBG): 
a. how often to test your blood sugar?    □ Yes  □ No 
b. what the recommended blood sugar targets are?  □ Yes  □ No 
c. how to ensure your meter is accurate?   □ Yes  □ No 
d. how to apply blood to the test strip?    □ Yes  □ No 
 
5. Did you receive basic nutrition information?    □Yes  □No 
 
6. Did your educator review these topics related to hypoglycemia 
(low blood sugar): 
a. how to prevent low blood sugar?    □ Yes  □ No 
b. the symptoms of low blood sugar?    □ Yes  □ No 
c. how to treat low blood sugar ?    □ Yes  □ No 
d. teach your family or support members how to help if  
you have low blood sugar?     □ Yes  □ No 
 
7. Did your educator review these items related to sick day management: 
a. checking your blood sugar every 4 to 8 hours when ill?   □Yes  □No 
b. adjusting your insulin dose when you are ill?   □Yes             □No  
c. knowing when to be seen by a healthcare provider?             □Yes  □No           
d. using easily digested / liquid carbohydrates if can’t  
tolerate solid food?                 □Yes            □ No 
e. how to prevent dehydration?                                                  □Yes              □ No 
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Appendix C 
Participant Letter of Information and Consent 
Study Title:  An Examination of Perceived Stress and Ways of Coping in Adult Patients 
Who Initiate Insulin Therapy  
Principal Investigator:  Maureen Loft, NP, M.Sc.N., CDE (maloft@uwo.ca) 
Faculty Supervisor: Dr. Cheryl Forchuk, RN, PhD, Associate Director Nursing Research 
Western University, Arthur Labatt Family School of Nursing (cforchuk@uwo.ca) 
Introduction: 
In order to achieve the best blood sugar control, patients with type 2 diabetes may be started on 
insulin.  Research has previously shown that patients respond differently and have different 
coping strategies when starting insulin therapy.   
The purpose of this letter is to provide you with the information that you require to make an 
informed decision about participating in this research.  This letter contains important information 
that you should understand about why the study is being conducted and what it will involve.  
Please take the time to read this carefully and feel free to ask questions if anything is not clear or 
there are words or phrases that you do not understand. 
What is the purpose of the research? 
The purpose of this research is to examine the relationships between perceived stress, ways of 
coping, and education that is guided by a best practice guideline.   
What does participation in the survey involve? 
If you agree to participate in the study you will be asked to complete 3 questionnaires during 
your two appointments with the education centre.  One questionnaire will ask you questions 
about your stress level. Another questionnaire will ask you about your ways of coping with 
different situations.  The third questionnaire will ask you about your confidence in giving 
yourself an injection and managing your diet.  The questionnaires will be completed during your 
regularly scheduled visits to the Diabetes Education Center.  The surveys will take 
approximately 20 minutes to complete.  All of your responses and health information will be 
anonymous and kept confidential. 
Who can be in the study? 
Patients who are 18 years of age or older, speak and understand English, have type 2 diabetes 
and are beginning or have recently begun insulin therapy may be asked to participate. Patients 
cannot participate in the study if they have previous used insulin therapy or are unable to 
complete the surveys. 
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If you decide to participate, you will be asked to sign an informed consent form. 
What are the possible risks? 
There are no known risks involved in participating in this study.  There is a small risk that some 
questions may cause you to experience emotional discomfort or distress.  Should you wish to end 
your participation in the study you may do so without providing a reason and your care will not 
be affected.  Your primary care caregiver or Endocrinologist will continue to be available to 
assist you. 
What are the possible benefits? 
Information provided by this study may be used by diabetes healthcare providers to improve 
education that they provide to people with diabetes.  It may assist healthcare providers to help 
patients develop strategies for coping with their diabetes.  You may not benefit directly although 
completing the questionnaires may provide you with the opportunity to reflect on your personal 
diabetes self-management and factors that influence it. 
What is the cost of participating in the study? 
There is no direct cost to you for participating in the study.  You will be providing your time to 
complete the questionnaires. 
Will I be reimbursed for participating in the study? 
You will not be paid to complete the surveys. 
Your rights: 
Participation in the study is voluntary.  You can refuse to participate, refuse to answer any 
questions or withdraw from the study at any time with no effect on your future care.  You have 
the right to be given all the important information about the study and what you will be asked to 
do.  You should only agree to participate in the study if you are satisfied and feel comfortable 
that you know enough about the study.  The study investigator may withdraw you from the study 
if your continued participation could impair your health.   
You do not waive any legal rights by signing the consent form. 
How will confidentiality be maintained? 
This study has been reviewed and approved by the Research Ethics Board for Health Sciences 
Research involving Human Subjects at the University of Western Ontario.  Your research 
records will be kept confidential and stored in a locked cabinet in a secure office.  If the study 
results are published, your name will not be used and no information that identifies you will be 
released or published without your explicit consent.  Your confidentiality will be respected.  
However, it is important to note that the original signed research consent form and the data 
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which will follow will be included in your health record.  Representatives of the research team, 
ethics review board, or regulatory bodies, such as Health Canada, may require access to your 
records for the purpose of monitoring the research. 
All information collected during the study will be stored until the completion of the study and the 
findings have been released. Your personal information will be destroyed within one year after 
the study is complete. Electronic data and paper based data sheets and analysis will be kept 
secured and destroyed through shredding or deletion and file removal ten years after publication 
of the study results. 
Who do I contact if I have a question about the study? 
If you have any questions about this research study please feel free to contact: 
Maureen Loft, NP, M.Sc.N., PhD student 
 
If you have any questions regarding your rights as a study participant, or the conduct of the study 
you may contact Dr. David Hill, Scientific Director, Lawson Health Research Institute. 
 
Thank-you for your interest in this study. 
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Consent form:  Study Title:  An Examination of Perceived Stress and Ways of Coping in 
Adult Patients Who Initiate Insulin Therapy  
I have read the Letter of Information, have had the nature of the study explained to me and I 
agree to participate.  All questions have been answered to my satisfaction.  I have received a 
copy of the patient information and consent form for this study. 
 
 
Name of Participant ________________________________ 
 
Signature of Participant ________________________________ 
 
Name of person obtaining consent ________________________________ 
 
Signature of person obtaining consent ________________________________ 
 
Date ________________________________ 
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